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Abstract 
Diabetes mellitus is an international epidemic affecting millions of individuals 
worldwide. In Canada, an estimated 3.4 million individuals are living with diabetes mellitus—
approximately 9.3 percent of the total population (Canadian Diabetes Association, 2018). A high 
prevalence of diabetes mellitus comes with a substantial cost; the direct annual cost associated 
with diabetes mellitus is expected to reach 3.1 billion dollars by 2020 (Bilandzic & Rosella, 
2017).  
The Canadian Pediatric Society recognizes that there are currently 33,000 children and 
adolescents aged 5-18 years old living with type 1 diabetes mellitus (T1DM) (as cited in the 
Diabetic Children’s Foundation, 2018). As children and adolescents with T1DM are in the 
process of developing physically and psychologically, they are at an increased risk of developing 
complications of diabetes that require short to long term attention and monitoring.  
The utilization of mobile technology to provide healthcare services is commonly referred 
to as mHealth. Such technology offers an opportunity to address the challenges of chronic 
disease management with this technology- intelligent population (Kitsiou, Paré, Jaana, & Gerber, 
B. 2017). As a component of the Master of Science in Nursing- Nurse Practitioner program at the 
University of Northern British Columbia, the following is an integrative review to answer the 
research question: Can mHealth, when monitored by a primary care provider, maintain 
hemoglobin A1c values in target range with adolescents between the ages of 10-19 diagnosed 
with type 1 diabetes mellitus?  
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Glossary 
All citations are from Medical Dictionary (2017) unless otherwise indicated.  
adherence- the act, action, or quality of adhering; to give support or maintain loyalty 
compliance- the act or process of complying to a desire, demand, proposal, or regimen or to 
coercion 
 
exogenous insulin- insulin not produced by the body (Donner, 2015) 
glucose- a crystalline sugar C6H12O6; specifically, the sweet colorless soluble dextrorotatory 
form that occurs widely in nature and is the usual form in which carbohydrate is assimilated by 
animals 
 
gluconeogenesis- formation of glucose within the animal body from precursors other than 
carbohydrates especially by the liver and kidney using amino acids from proteins, glycerol from 
fats, or lactate produced by muscle during anaerobic glycolysis 
 
hard endpoint- an endpoint that is well-defined and can be measured objectively (European 
Patients’ Academy, 2018a) 
 
hemoglobin A1c- a blood test utilized to measure the amount of HgbA1c in the blood which 
provides an accurate long-term measure of an individual’s average blood glucose level within the 
previous three months (Pagana, K., Pagana, T., & Pike-MacDonald, 2012) 
 
hyperglycemia- an excess of sugar in the blood 
hyperketonemia- a condition marked by an abnormal increase of ketone bodies in the 
circulating blood —called also ketonemia 
 
hyperosmolality- the condition especially of a bodily fluid of having abnormally high 
osmolality 
 
ketosis- an abnormal increase of ketone bodies in the body 
 
lipogenesis- the formation of fat; specifically, the formation of fatty acids from acetyl coenzyme 
A in the living body and especially in adipose tissue and the liver 
 
metabolic acidosis- acidosis resulting from excess acid due to abnormal metabolism, excessive 
acid intake, or renal retention or from excessive loss of bicarbonate (as in diarrhea) 
 
 
 
 
 
x 
osmotic diuresis- increased urination due to the presence of certain substances in the fluid 
filtered by the kidneys. This fluid eventually becomes urine. These substances cause additional 
water to come into the urine, increasing its amount. Causes include increased glucose in the 
blood and certain medications (US National Library of Medicine, 2018) 
pancreatic beta cells- any of the insulin-secreting pancreatic cells in the islets of Langerhans 
 
pH- a measure of acidity and alkalinity of a solution that is a number on a scale on which a value 
of 7 represents neutrality and lower numbers indicate increasing acidity and higher numbers 
increasing alkalinity and on which each unit of change represents a tenfold change in acidity or 
alkalinity and that is the negative logarithm of the effective hydrogen-ion concentration or 
hydrogen-ion activity in gram equivalents per liter of the solution 
 
polydipsia- excessive or abnormal thirst 
polyuria- excessive secretion of urine  
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CHAPTER ONE: INTRODUCTION 
Diabetes mellitus has developed in to an international epidemic affecting millions of 
people around the world. In Canada, an estimated 3.4 million individuals are living with diabetes 
mellitus—approximately 9.3 percent of the total population (Canadian Diabetes Association 
[CDA], 2018). The total number of Canadians diagnosed with diabetes is expected to increase to 
5 million by the year 2025 with a projected annual direct cost of $3.1 billion in 2020—increases 
of 44 percent to prevalence and 25 percent to cost (CDA, 2018; Bilandzic & Rosella, 2017). 
Canada is recognized as having one of the highest incidence rates for type 1 diabetes mellitus 
(T1DM) globally in children and adolescents under the age of fourteen (DiaMond Project Group, 
as cited in the Public Health agency of Canada [PHAC], 2011). According to the Canadian 
Pediatric Society (CPS) 33,000 children and adolescents between the ages of 5-18 years old are 
living with T1DM (as cited in the Diabetic Children’s Foundation, 2018). Although Canada does 
not currently have statistics available for the prevalence of T1DM and T2DM in adolescents, 
British Columbia’s Provincial Health Services Authority (2010) estimated that approximately 
ninety percent of diabetes mellitus cases in the paediatric population were type 1 and 
approximately ten percent were type 2, however the data was extracted over an eleven-year 
period ending in 2007. Although an increase in the prevalence of T1DM has been documented in 
several countries globally, the rationale for the rise remains unclear (PHAC, 2011).   
Type 1 diabetes mellitus (T1DM), previously called insulin-dependent or juvenile 
diabetes, results in an insufficient amount of insulin in the body due to two possible reasons: (1) 
the destruction of pancreatic beta cells which produce insulin, or (2) idiopathic causes (Brashers, 
Jones, & Huether, 2014). An excess of glucose in the body results due to the insufficiency of 
pancreatic beta cells, placing the individual at risk for potentially life-threatening complications 
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if left untreated. Unlike T1DM, T2DM is predominately associated with insulin resistance and 
strongly linked to obesity (Brashers et al., 2014). Both T1DM and T2DM place an individual at 
risk for cardiovascular disease, retinopathy, nephropathy, and neuropathy (Brashers et al., 2014). 
However, because T1DM is generally diagnosed at a younger age there is an increased risk of 
developing long-term complications at an earlier age (PHAC, 2011). Furthermore, because 
individuals diagnosed with T1DM rely on exogenous insulin to normalize metabolic processes, 
there is an additional risk of immediate and acute complications (PHAC, 2011).  
Adolescents diagnosed with T1DM are known to have less effective metabolic control in 
comparison to other age categories (Moore et al., 2013). While the onset of T1DM generally 
occurs before or during adolescence it is recognized that this stage of development is a time of 
significant physical, cognitive, and psychological change. In addition, youth are at an increased 
likelihood of engaging in high-risk behaviours (for example, alcohol and drug use) and 
developing mental health conditions (Moore et al., 2013; World Health Organization [WHO], 
2017). As a result of onset in childhood or adolescence, parental support and monitoring is a key 
aspect of childhood T1DM health care management (Smith, Cheater, & Bekker; Wallander & 
Varney, 1998). While the rate of engaging in risk-taking behaviour is similar amongst 
adolescents diagnosed with T1DM and non-T1DM adolescents, the outcome for an individual 
with T1DM who engages in high-risk behaviour is linked to poor metabolic outcomes, personal 
and family stress, and mental illness (Moore et al., 2013). 
As a result of software, connectivity, and increased social economy, digital access has 
become widely available to younger populations across a broader network and geography. 
Subsequently, the use of technology in the management of life long or chronic conditions has 
developed significantly and continues to evolve. Originally, the term telemedicine encompassed 
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health care services offered from a distance.  However, the use of technology in health care has 
expanded resulting in a range of sub-categories within a framework of telemedicine, including 
mHealth (Kitsiou et al., 2017). As such, mHealth utilizes mobile technologies to provide health 
care services; in relation to adolescents diagnosed with T1DM, mHealth has the potential to: 
•! support adolescents diagnosed with T1DM in gaining autonomy in management of their 
chronic disease; 
•! provide parents with the ability to monitor their child’s daily T1DM-related values;  
•! provide health care providers the opportunity to communicate with the patient, monitor 
daily T1DM values, provide T1DM guidance and counseling, and create and revise 
treatment plans accordingly (Kitsiou et al., 2017).  
The following is an integrative review investigating if mHealth, when monitored by a 
primary care provider (PCP), can maintain HgbA1c values in target range with adolescents 
between the ages of 10-19 diagnosed with T1DM. Glycosylated hemoglobin, or HbgA1c, is a 
blood test utilized to measure the amount of HgbA1c in the blood and provides an accurate long-
term measure of an individual’s average blood glucose level within the previous three months 
(Pagana, K., Pagana, T., & Pike-MacDonald, 2012; Juarez et al., 2013). A stable HgbA1c of less 
than 7.0-7.5 percent is often associated with a reduction in complications associated with T1DM 
such as long-term microvascular and macrovascular risks and avoidance of excessive episodes of 
severe hypo-or hyper-glycemia (Canadian Diabetes Association Clinical Practice Guidelines 
Expert Committee [CDACPGEC], 2013; Juarez et al., 2013; Wherrett, Huot, Mitchell, & 
Pacaud, 2013). The Diabetes Control and Complications Trial Group [DCCT] (1995), recognized 
that a ten percent reduction in the HgbA1c of individuals diagnosed with T1DM resulted in a 40 
to 50 percent reduction in retinopathy in addition to a decrease in microvascular complications; 
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although the trial was conducted with a predominately adult population, it emphasizes the 
importance of maintaining HgbA1c in therapeutic range in order to limit complications (Nathan, 
2014). 
Following an integrative review approach, this paper will provide background context of 
the key ideas associated with the research topic, including: a definition of adolescence; the 
pathophysiology, clinical presentation, complications, HgbA1c, diagnostic criteria and glycemic 
targets, and management of T1DM; adherence to T1DM management amongst adolescents; 
parental or caregiver involvement with adolescents diagnosed with T1DM; an overview of the 
use of technology in the adolescent population; a summary of the concept of mHealth; and the 
role of primary care providers in chronic disease management. The search strategy conducted to 
answer the posed research question will be identified, including: conceptualization and the 
preliminary search, the focused search, and analysis of the articles selected for the integrative 
review. The common themes identified from the analysis will then be expanded in the Findings 
section followed by the Discussion section which will synthesize the Findings and include 
recommendations for the clinical setting, education, and future research.  
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CHAPTER TWO: BACKGROUND AND CONTEXT 
 In order to gain a better understanding of the complexities associated with adolescent 
individuals diagnosed with T1DM, there are several key components that need to be addressed in 
further detail. These components include: adolescence; the pathophysiology, clinical 
presentation, complications, HgbA1c, diagnostic criteria and glycemic targets, and management 
of T1DM; adherence to T1DM regimens amongst adolescents; parental or caregiver involvement 
with the T1DM management plan for adolescents; the correlation between technology and 
adolescents; an overview of technology in health care including a summary of the concept of 
mHealth; and the role of primary care providers. The following sections will expand the key 
components with an aim to contextualize the place mHealth has within primary care 
management with the T1DM adolescent. 
Adolescence 
There are various meanings to the term adolescence throughout the literature. The World 
Health Organization [WHO] (2017, para. 2) and the Canadian Paediatric Society [CPS] (2016, 
para. 3) both recognize adolescence as the growth and development phase between childhood 
and adulthood, from the ages of ten to nineteen. The CPS further identifies that “adolescence 
begins with the onset of physiologically normal puberty, and ends when an adult identity and 
behavior are accepted” (2016, para. 3). The American Psychological Association [APA] 
describes the term adolescence as a period of physical growth and social and cognitive 
development, or the amount of time from the onset of puberty to the period when an individual 
obtains financial independence (2002). Furthermore, the WHO identifies adolescence as one of 
the most rapid periods of growth and development across the lifespan (2017). The WHO and 
CPS’ definition of adolescents will be recognized within this paper—an individual between the 
 
 
6 
ages of ten and nineteen experiencing rapid growth and development between childhood and 
adulthood. 
During adolescence several developmental milestones occur. Such milestones include: 
sexual maturation, physical growth, increased social and economic responsibilities and 
independence, increased ability for abstract reasoning due to pre-frontal cortex development, the 
acquisition of skills necessary for maintaining adult relationships and responsibilities, and the 
development of one’s identity (WHO, 2017; APA, 2002). Furthermore, adolescence is a period 
associated with poor understanding of the correlation between risks and consequences due to the 
evolving development of the pre-frontal cortex which is responsible for executive functions, 
including: decision-making, organizational skills, impulse control, and long-term planning and 
goal (WHO, 2017). The continuing development of the pre-frontal cortex during adolescence 
contributes to challenges associated with chronic disease management, such as T1DM, therefore 
adolescents diagnosed with T1DM benefit from being closely monitored and well-supported.  
Type I Diabetes Mellitus in Adolescents 
Diabetes mellitus is a syndrome characterized by hyperglycemia due to defects in insulin 
secretion, insulin action, or a combination of both (Brashers et al., 2014). T1DM is a 
predominately autoimmune syndrome whereas type 2 diabetes mellitus is characterized by 
insulin deficiency and resistance. The diagnosis of T1DM in childhood or adolescence can be 
challenging for the individual; however, parents, care providers, school teachers, sports coaches, 
etc. are also impacted by the attention that an adolescent with T1DM requires. Regular insulin 
injections, blood glucose monitoring, and diet and physical exercise needs can be life-changing, 
in addition to the necessary attention required when acute and chronic complications develop 
(Caferoğlu, İnanç, Hatipoğlu & Kurtoğlu, 2016). The following section will discuss the 
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pathophysiology, clinical presentation, complications, HgbA1c, diagnostic criteria and glycemic 
targets, and management of T1DM. 
Pathophysiology 
The disease process of T1DM is multifaceted. Pancreatic beta cells which produce insulin 
in the pancreas are destroyed resulting in insulin deficiency and hyperglycemia secondary to a 
defective metabolism of fat, protein, and carbohydrates in the body (Atkinson, von Herrath, 
Powers, & Clare-Salzler 2015; Brashers et al., 2014; Paschou, Papadopoulou-Marketou, 
Chrousos, & Kanaka-Gantenbein, 2018; Smaldone, Steiner, & Whittemore, 2017). As glucose 
accumulates in the body due to insulin deficiency, reduced effectiveness, or both, the kidneys 
become unable to maintain the amount of glucose in the body resulting in osmotic diuresis and 
symptoms of polyuria and polydipsia (Brashers et al., 2014; Smaldone et al., 2017). 
Furthermore, weight loss occurs due to fluid loss and loss of body mass which is associated with 
the breakdown of protein and fat (Brashers et al., 2014). Because insulin stimulates lipogenesis 
which results in stored fats, there is an increased amount of fatty acids delivered to the liver 
which causes hyperglycemia due to increased gluconeogenesis  (Brashers et al., 2014). Insulin 
deficiency further contributes to the release of fatty acids and an increased production of ketone 
bodies by the liver at a rate that exceeds use by the body; the increase in ketone bodies decreases 
the pH (to an acidotic state) which triggers the buffering system associated with metabolic 
acidosis (Brashers et al., 2014; National Health Service [NHS], 2017). At this stage, diabetic 
ketoacidosis may occur which is life-threatening and initially caused by the lack of circulating 
insulin; approximately one quarter of children with new-onset T1DM present in diabetic 
ketoacidosis (Brashers et al., 2014; NHS, 2017; Smaldone et al., 2017).  
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There are two distinct types of T1DM:  autoimmune and non-autoimmune. In 
autoimmune diabetes, both environmental and genetic factors are thought to trigger cell-
mediated destruction of the beta cells which are responsible for producing insulin in the pancreas 
(Brashers et al., 2014). The result of beta cell destruction leaves the body with minimal or no 
insulin which is required to avoid hyperglycemia and potential short and long-term 
complications. T1DM that is autoimmune-related is recognized as a subtype and identified as 
type 1A, contributing to 95% of all T1DM cases (Brashers et al., 2014; Masharani, 2016). Type 
1B diabetes mellitus is of idiopathic (non-autoimmune) origin accounting for approximately 5% 
of all T1DM (Brashers et al., 2014; Masharani, 2016).  These will be explained briefly in the 
next subsections. 
 T1DM 1A. Here, the immune system attacks beta cells resulting in reduced insulin 
secretion. Autoimmunity has been associated with genetic or environmental factors which cause 
autoantigens to form on beta cells and travel throughout the blood and lymphatic system which 
triggers a response from the immune system resulting in beta cell destruction and ultimately 
insulin deficiency and hyperglycemia (Brashers et al., 2014; Kalyani, 2017).  
Approximately one-third of T1DM susceptibility is attributed to genes; the other two-
thirds are related to environmental factors (Masharani, 2016). The lifetime risk of developing 
T1DM is significantly higher if an individual has a family history of the disease (Brashers et al., 
2014). Furthermore, there are several additional factors suggested to be linked to an increased 
risk of T1DM 1A including: viral infections (particularly enterovirus), diet (specifically exposure 
to cow’s milk, fruit, or gluten at an early age), higher socioeconomic status, exposure to toxins. 
obesity, vitamin D deficiency, gut microbiota reduction, and perinatal factors including maternal 
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age, history of preeclampsia, neonatal jaundice, and a low birth weight (Brashers et al., 2014; 
Saberzadeh-Ardestani et al., 2018). 
 T1DM 1B. Approximately 5% of individuals diagnosed with T1DM have no evidence of 
pancreatic autoimmunity to explain the body’s inability to provide an adequate amount of 
insulin; this subgroup of diabetes mellitus is identified as “idiopathic type 1” or type 1B 
(Kalyani, 2017; Papadakis & McPhee, 2016). Individuals diagnosed with type 1B diabetes 
mellitus are predominately Asian or African; however, there is little information available on 
type 1B diabetes mellitus available across ethnicities resulting in possible population bias 
(Balasubramanian et al., 2003; Kalyani, 2017; Papadakis & McPhee, 2016). Despite variation in 
the pathophysiology presentation of either type of T1DM (A or B), the clinical presentation 
follows a similar pattern and is discussed in the following section.  
Clinical Presentation 
T1DM is the most common type of diabetes in children under the age of 12; diagnosis of 
T1DM is extremely rare under the age of nine months and peaks between the ages of 11-13 years 
(Brashers et al., 2014; Smaldone et al., 2017). There is no gender difference of T1DM in the 
overall incidence between males and females; however the peak onset of T1DM is slightly 
earlier in females in comparison to males (Brashers et al., 2014). Furthermore, T1DM has a 
higher prevalence amongst those of Caucasian decent; the rates are approximately 1.5-2 times 
higher that non-white individuals (Brashers et al., 2014).  
T1DM was historically thought to have an abrupt onset, however research has confirmed 
that it occurs over an extended period of time in which beta cells of the pancreas are destroyed 
leading to insulin deficiency and hyperglycemia (Brashers et al., 2014; Smaldone et al., 2017). 
Prior to hyperglycemia, approximately 80% to 90% of the function of insulin-secreting beta cells 
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must be lost (Brashers et al., 2014). The symptom set of T1DM may present clinically in a 
variety of ways. The most common presentation of T1DM in children and adolescents is a 
combination of: polydipsia, polyuria, polyphagia, weight loss, and fatigue contributed to 
hyperosmolality and hyperketonemia from an increased amount of circulating glucose and fatty 
acids and insulin deficiency (Brashers et al., 2014; Masharani, 2016). Polyuria and polydipsia are 
present in approximately 90 percent of individuals; however, these symptoms may become more 
apparent with a thorough health history including nocturia (nighttime voiding), bedwetting, an 
increased number of wet diapers or abnormally wet diapers, and persistent thirst (Brashers et al., 
2014). If left unrecognized and untreated for a significant amount of time, T1DM may progress 
into diabetic ketoacidosis (DKA) which is a life-threatening condition. The complications 
associated with T1DM will be discussed in the following section. 
Complications  
 Diabetic complications are a significant cause of morbidity and mortality amongst 
individuals diagnosed with T1DM (Smaldone et al., 2017; You & Henneberg, 2016). Individuals 
diagnosed with T1DM are ten-times more likely to experience a cardiac event (macrovascular 
complication) than non-diabetic individuals of the same age (Atkinson, Eisenbarth, & Michels, 
2014). In the adolescent population, poor glycemic control, changing physiology, and 
behavioural and adherence issues can be causative factors in acute and chronic complications of 
T1DM (Al-Agha, Ocheltree, & Hakeem, 2011). However, daily self-monitoring of blood 
glucose, daily insulin injections, regular hemoglobin A1c (HgbA1c) measurements, and close 
monitoring of physical activity can aid in the reduction of T1DM-associated complications (Al-
Agha et al., 2011; CDACPGEC, 2013). 
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  In addition to microvascular and macrovascular complications, undesired outcomes 
specific to the T1DM adolescent population have been identified, including: cognitive alterations 
affecting learning and executive functions, brain structure alterations, brain activity alterations, 
sleep disorders, disrupted eating behavior/eating disorders, self-reported low quality of life, 
depression and anxiety, and increased absences from school (Litmanovitch, Geva, & Rachmiel, 
2015; CDACPGEC, 2013). Ultimately, glycemic control within target range can reduce the risk 
of micro and macro-vascular complications and undesired outcomes. 
Diabetic ketoacidosis. DKA, the leading cause of morbidity and mortality amongst 
children and adolescents diagnosed with T1DM, is a result of absolute insulin deficiency (Jeha & 
Haymond, 2016; Diabetes Canada, 2018). The diagnosis of DKA involves hyperglycemia (a 
blood glucose greater than 11 mmol/L), metabolic acidosis (a venous pH less than 7.3 or plasma 
bicarbonate greater than 15 mmol/L), and ketosis (ketones present in urine, blood, or both) (Jeha 
& Haymond, 2016). The clinical presentation of DKA may include polydipsia, polyuria, 
polyphagia, weight loss, and fatigue in addition to a fruity smelling breath, tachycardia, and 
neurological symptoms including decreased level of consciousness and lethargy (Brashers et al., 
2014; Diabetes Canada, 2018; NHS, 2017). Vomiting may also be present due to dehydration. 
There are three levels of severity of DKA, including: mild, moderate, and severe. Unfortunately, 
nearly 50% of children under the age of 4 and 25% of those between the ages of 5 and 15 present 
with DKA as the initial sign for T1DM (Brashers et al., 2014; Smaldone et al., 2017). Children 
and adolescents presenting with DKA are often admitted to hospital requiring rehydration and 
intravenous insulin therapy; in British Columbia, those with mild DKA, known T1DM, and 
reliable support may be managed at home or as an outpatient, however all individuals presenting 
with moderate or severe DKA are managed optimally in a medical facility (Brashers et al., 2014; 
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Metzger, 2010). As there are significant risks associated with hyperglycemia and hypoglycemia, 
it is essential for adolescents diagnosed with T1DM to stay within their glycemic target in order 
to avoid complications. Glycohemoglobin testing, diagnostic criteria, and glycemic targets of 
T1DM will be discussed in the following section. 
HgbA1c, Diagnostic Criteria and Glycemic Targets 
 HgbA1c, or a glycohemoglobin test, is recognized as “a blood test that checks the amount 
of sugar (glucose) bound to hemoglobin in red blood cells” (Government of Alberta, 2020). 
Individuals who have T1DM or T2DM have an elevated amount of glucose bound to 
hemoglobin. An HgbA1c test is used to diagnose pre-diabetes, T1DM, T2DM, gestational 
diabetes, or for the purpose of monitoring diabetes mellitus (Government of Alberta, 2020; 
HealthLinkBC, 2018). Unlike self-monitoring of blood-glucose which evaluates the blood sugar 
in the moment that the test is conducted, HgbA1c captures the amount of glucose in the blood 
over the previous two to three months as the life cycle of a red blood cell is three to four months 
in length (Government of Alberta, 2020; HealthLinkBC, 2018). 
The diagnostic criteria for diabetes mellitus are complex but offer important 
considerations when exploring HbA1c values as key goals in treatment. Diabetes Canada (2018) 
advises that the diagnosis of diabetes mellitus (both types 1 and 2) in children, adolescents, and 
adults includes the following criteria:  
•! a fasting plasma glucose ≥ 7.0 mmol/L (no intake for a minimum of 8 hours prior to the 
test); 
•! a hemoglobin A1C ≥ 6.5% (not recommended as the sole diagnostic test in children and 
adolescents); 
•! a 2-hour plasma glucose ≥ 11.1 mmol/L in a 75g oral glucose tolerance test; 
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•! a random plasma glucose of ≥ 11.1 mmol/L in an individual displaying symptoms of 
hyperglycemia. 
If an asymptomatic individual suspected of having diabetes mellitus tests positive to one of the 
above tests, the test is considered a false positive; a repeat test is required to provide 
confirmation of diagnosis, preferably the same test scheduled on a different day in a timely 
manner (Chiang et al., 2018; Diabetes Canada, 2018; Medical Services Committee, 2015). When 
an individual is symptomatic of diabetes mellitus, secondary testing is not necessary to confirm 
diagnosis. While HgbA1c testing is not currently recommended for diagnosis in children and 
adolescents, there is ongoing work exploring the value in using HgbA1c in the future (Chiang et 
al., 2018; Diabetes Canada, 2018).  
 To distinguish between T1DM and T2DM, determining the presence of pancreatic 
autoantibodies is necessary. The types of autoantibodies include: islet cell cytoplasmic 
autoantibodies (ICA), insulin autoantibodies (IAA), glutamic acid decarboxylase autoantibodies 
(GADA), glutamic acid decarboxylase-65 autoantibodies (GAD-65), insulinoma-associated-2 
autoantibodies (IA-2A), and zinc transporter-8 Autoantibodies (ZnT8A) (American Association 
for Clinical Chemistry [AACC], 2018; Donner, Champaneri, & Saudek, 2015). GAD-65 
autoantibodies are present at clinical presentation in approximately 80 percent of individuals 
diagnosed with T1DM whereas IAA is the first marker present in children who are at-risk for 
T1DM and is present at diagnosis in approximately 70 percent of cases (AACC, 2018). 
However, a lack of autoantibodies does not rule out the presence of T1DM as the disease process 
may be idiopathic (type 1B), not autoimmune (type 1A).  
Once an individual is diagnosed with T1DM, maintaining glycemic control is critical in 
preserving homeostasis and reducing the risk of complications. The glycemic targets 
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recommended for children and adolescents are: an HgbA1c ≤7.5%, a fasting (preprandial) 
glucose of 4 to 8 mmol/L, or a two-hour post-prandial glucose of 5 to 10 mmol/L (Wherrett et al, 
2018). However, if a child or adolescent is susceptible to hypoglycemic episodes a higher 
HgbA1c and preprandial target may be advised by the individual’s diabetic team (American 
Diabetes Association, 2018; Wherrett et al, 2018). In order to maintain HgbA1c within a 
therapeutic range, measures are taken to reduce hypo and hyperglycemic events and regulate 
HgbA1c. The following section will provide an overview of the management of T1DM. 
 Management 
There is currently no cure for T1DM; therefore, individuals diagnosed with T1DM have a 
chronic disease that can be life-limiting. Smaldone et al., recognize that “the treatment goals for 
children [and adolescents] are to achieve normal growth and development, optimal glycemic 
control, and positive psychosocial adjustment to diabetes while minimizing acute or chronic 
complications” (2017, p. 610). Therefore, children and adolescents diagnosed with T1DM must 
learn to self-manage their disease to in order to minimize risk and associated complications 
(Distiller, 2014). Effective management is critical if outcome goals of HgbA1c levels are to be 
released by the adolescent.  However, management is complex as Coffen (2009) reports that 
there are over six hundred tasks an individual will need to master, including; understanding of 
the etiology of the disease, knowledge of pharmacology (including insulin), insulin technique, 
blood glucose and ketone monitoring, diet, exercise, hypoglycemia, hyperglycemia, diabetic 
ketoacidosis, illness and stress, traveling, complications, general knowledge, and miscellaneous 
items. Glycemic control, as evidenced by HgbA1c monitoring, has been associated with reducing 
or preventing complications (Diabetes Control and Complications Trial Research Group, 1995).   
 
 
15 
Insulin is necessary for glycemic control and is a mainstay of management for 
adolescents diagnosed with T1DM. Insulin is initiated at the time of diagnosis and is a complex 
and often overwhelming process for patients (American Diabetes Association, 2019; Diabetes 
Canada, 2018). When an insulin regimen is initiated, there are a multitude of factors to consider 
from a health care provider perspective in terms of selection. Such factors include: age, overall 
health/co-existing chronic diseases, treatment goals, lifestyle, diet, hypoglycemia awareness, 
ability to self-manage, and adherence to treatment regimen as there is not a “one size fits all” 
strategy to selecting insulin and there are multiple types of insulin available in Canada (Diabetes 
Canada, 2018). Furthermore, patients diagnosed with T1DM often require multiple types of 
insulin complicating the process further (Diabetes Canada, 2018). 
The management of T1DM in adolescents is additionally complicated by physiological 
and psychological changes of adolescence. Youth between the ages of 10-19 years are 
experiencing physical, psychosocial and emotional challenges by nature of their growth and 
cognitive development (Datye et al., 2015; Taddeo, Egedy, & Frappier, 2008). Maturation and 
progression towards independence is essential at this stage. In British Columbia, adolescents and 
their families work together with primary care providers, specialists, nurses, social workers, 
therapists, school, and community and government organizations to ensure there is a smooth 
transition to the adult care system; key components of this process include providing adolescents 
and their families with the confidence, skills, and knowledge required to transition to adult care 
(BC Children’s Hospital, 2016). For youth with T1DM, the positive influence of health 
education and management are critical in promoting self-efficacy and subsequently the transition 
towards adult care provider systems (Paterick, Patel, Tajik, & Chandrasekaran, 2017). Extensive 
education involving the disease process, management, and potential complications of T1DM is 
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offered to youth from health care providers at the initial time of diagnosis and support is most 
often maintained, by paediatric-led teams, until the individual turns 19 years of age; at this time, 
primary care providers take a greater responsibility in on-going care (Provincial Health Services 
Authority [PHSA], 2017; Wherrett, Huot, Mitchell, & Pacaud, 2013). One major worry is 
associated with development, access, and independence and is commonly framed within the 
concept of adherence to medication regimen. As non-adherence has significant impact on short 
and long-term health outcomes for individuals diagnosed with T1DM, it warrants further 
examination which will be provided in the following section. However, it is important to briefly 
recognize the management of diabetes in schools in British Columbia as adolescents spend a 
large amount of their time in this environment and must learn to manage their disease in various 
contexts. 
Due to management complexities of T1DM in children and adolescents including various 
types of insulin, the risk for hypo and hyper-glycemic events and diabetic complications, periods 
of increased physical activity, etc. adolescents diagnosed with T1DM must learn to manage their 
chronic disease in various contexts.  A collaborative effort by the Ministries of Health, 
Education, and Children and Family Development resulted a guideline for children and 
adolescents enrolled in public schools diagnosed with T1DM; ‘Supporting Students with Type 1 
Diabetes in the School Setting’ outlines “the provincial standards to support students with T1DM 
in the school setting, and articulate[s] the roles and responsibilities of parents/guardians, the 
school administer, and the Health Authorities” (2015, p. 2). Recognizing the challenges that 
children and adolescents diagnosed with T1DM encounter, the ultimate goal of the program is to 
ensure students diagnosed with T1DM are offered an equitable education in a safe learning 
environment.  
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Despite abundant literature available linking well-managed T1DM with an HgbA1c 
within target range to reduce complications, non-adherence to T1DM management can be a 
challenge amongst the adolescent population especially when multiple environments are a factor. 
Not only do different environments have a potential to impact diabetic management and health 
outcomes, adherence also has a significant impact on health outcomes and the risk for 
complications. The following section will discuss adherence to T1DM management in 
adolescents. 
Adherence  
The annual costs associated with non-adherence of individuals diagnosed with diabetes are 
significant. T1DM is a costly chronic condition costing between 100 and 289 billion dollars in 
the United States and is linked to approximately 125,000 deaths and 10% of hospitalizations 
annually, (Dunbar-Jacob & Mortimer-Stephens, 2001; Viswanathan et al., 2012; Watanabe, 
McInnis, & Hirsch, 2018).While similar statistics are unavailable for Canada, T1DM affects 
approximately 3.4 million Canadians which is expected to increase to 5 million by 2025 
(Bilandzic & Rosella, 2017). Well-managed physical health in T1DM is often labeled as good 
adherence within health care environments. Venes identifies adherence as “the extent to which a 
patient’s behavior coincides with medical advice”; whereas non-adherence is the contrary and 
associated with negative connotation, not following medical advice, ineffectiveness of treatment, 
and poor health care outcomes (2001, p. 461; WHO, 2003). The concept of adherence is relevant 
to this integrative review since adolescence is a developmental period during which adherence is 
low (Wherett et al., 2018). In terms of mHealth and adolescents diagnosed with T1DM, mHealth 
is proposed as an approach to improve adherence management. 
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 Adherence-related tasks relevant to an adolescent diagnosed with T1DM may include: 
routine blood glucose monitoring, insulin and/or glucose administration, additional medication 
administration, attention to diet and activity, attending medical appointments, having routine 
blood draws at the laboratory, obtaining and maintaining medical supplies, etc. (Gandhi et al., 
2016). Amongst individuals diagnosed with T1DM, adherence is associated with maintaining 
glycemic control as evidenced by HgbA1c levels (Hamine et al., 2015; Horne et al., 2005). As 
T1DM is a complex chronic disease and adolescence is associated with poor adherence, parental 
or caregiver involvement and support is essential which will be discussed in the following 
section. 
Parental Involvement 
T1DM is a complex chronic disease requiring multiple daily tasks and attention to detail, 
therefore a lack of T1DM knowledge or failure to engage in behavioural tasks may result in short 
or long-term complications requiring further medical care (Herge et al., 2012; Taddeo et al., 
2008). Due to the attention of detail required and risk of patient safety of not engaging in such 
tasks, adolescents diagnosed with T1DM may feel extremely overwhelmed. Therefore, parental 
involvement and support in the management of T1DM is necessary as adolescents work towards 
increasing their independence in managing their chronic disease.  
An adolescent’s relationship with his or her parents can play a significant role in the 
development of self-care, adherence to diabetic care routine and metabolic control (Berg et al, 
2011). However, the responsibility of managing a child or adolescent diagnosed with a chronic 
disease, such as T1DM, increases the demands of parenting and providing care significantly 
(Smith et al., 2013; Wallander & Varney, 1998). In addition to regular demands of parenting, 
parents and care givers must adapt to disease-specific demands, including: maintenance of 
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treatment and care, avoiding complications, social and financial constraints, and maintenance of 
family relationships and life (Smith et al., 2013). When there are effective strategies to manage 
the adolescent’s condition and cope with disease-associated stressors there, is a noticeable 
improvement in family functioning (Smith et al., 2013). Although close monitoring of an 
adolescent may be beneficial to T1DM outcomes, it may also hinder the parental-adolescent 
relationship as adolescents seek independence. 
Parents of adolescents diagnosed with T1DM recognize that adolescent self-management 
is reduced when scolding, judging, checking, nagging, or becoming emotional is displayed by 
the parent and ultimately associated with the stress and anxiety of having a child diagnosed with 
a complex chronic disease (Carroll, Downs, & Marrero, 2007; Moore et al., 2013). Parents and 
care givers often struggle with providing the adolescent with autonomy in relation to managing 
T1DM because adolescents often recognize themselves as more capable and independent at an 
earlier age than their parents, (Butner et al., 2009; Carroll et al., 2007). Additional support during 
this transitional time, when adolescents diagnosed with T1DM are seeking self-efficacy and 
independence, may foster healthier relationships with parents. In the context of this paper, 
mHealth could provide a platform for reassurance as parents could gain access to adolescent’s 
diabetic data (such as blood glucose readings or insulin dosages) and have comfort in knowing 
there is increased accessibility to communication between adolescents and health care 
providers—depending on the app selected. Adolescents are well-known for their usage of 
electronic devices and software, therefore utilizing technology to support management of T1DM 
in adolescents may promote independence, improve adherence and subsequently maintain 
HgbA1c within target range (George & Odgers, 2014). The following section will discuss the 
relationship between technology and adolescents. 
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Technology and Adolescents 
 Adolescents have traditionally been keen to explore new technologies and are amongst 
one of the highest user groups (George & Odgers, 2014; Moawad & Ebrahen, 2016). Due to the 
convenience and accessibility delivered by mobile devices, 92% of American adolescents report 
utilizing the internet daily; furthermore, 24% of those identified reported being online almost 
constantly (Lenhart, 2015). In Canada, approximately 24% of Grade 4 students, 52% of Grade 7 
students, and 85% of Grade 11 students own or have access to a cellphone or smartphone which 
is associated with familial socioeconomic status (Johnson, 2015). Anderson and Jiang (2018) 
report that approximately 95 % of Canadian teens between the ages of 13 and 17 have or have 
access to a mobile phone; a 22% increase from the previous statistics in 2014-2015. Of the 95% 
of teens, almost all send and receive text messages; the average teen sends approximately 30 text 
messages per day (Anderson & Jiang, 2018, para. 5). Additionally, the majority (51%) of grade 
11 (ages 16/17) students are sleeping with their mobile devices in reach; 20% of grade 4 (ages 
9/10) (Johnson, 2015).  
Canadian youth utilize technology and the Internet for many reasons, including: 
socializing, news and current events, seeking information regarding health and well-being 
(physical and mental health, sexuality, relationship concerns, etc), playing games, etc. (Johnson, 
2015). Furthermore, Skinner, Biscope, Polan, and Golderg (2003) identify that adolescents 
utilize technology to seek information regarding school, interactions with friends and peer 
groups, medical conditions, body image and nutrition, violence and safety, and sexual health 
care. Sixty-seven percent of adolescents polled were interested in seeking health-related 
information via technology (i.e. the internet) although the quality of the content of the 
information is not consistently from reputable sources (Skinner et al., 2003). 
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Despite there being a significant amount of beneficial and resourceful ways to utilize 
technology, there are some associated risks and concerns. Such risks and concerns include: cyber 
trolling (bullying), online grooming, pornography, pro-self-harm and eating disorder sites which 
promote experimentation, isolations, reduced attachment to parents or caregivers, a decline in 
face-to-face relationships, overreliance, limited connectivity in some graphical areas, privacy and 
safety, cost, the risk of losing a device, and low literacy and high diversity of users (Barton, 
2012; Garrity, 2017; Moawad & Ebrahen, 2016). Regardless of the risks and concerns associated 
with utilizing technology, adolescents remain keen to explore and make use of technology which 
may provide benefit to those adolescents diagnosed with T1DM. The following section will 
discuss the use of technology in health care. 
Technology in Health Care 
Telemedicine, its approach, application and impact has been studied for over fifty years 
and continues to evolve. The World Health Organization [WHO] (1997, as cited in WHO 2010) 
define telemedicine as:  
The delivery of health care services, where distance is a critical factor, by all health care 
professionals using information and communication technologies for the exchange of 
valid information for diagnosis, treatment, and prevention of disease and injuries, 
research and evaluation, and for the continuing education of health care providers, all in 
the interest of advancing the health of individuals and their communities. (p. 8) 
Telemedicine has the potential to improve a patient’s health care outcomes and accessibility to 
health care services while decreasing health care costs (Flodgren, Rachas, Farmer, Inzitari, & 
Shepperd, 2015). Furthermore, Flodgren et al. (2015) recognize that telemedicine provides a 
variety of functions, often falling in to one of six categories, associated with the patient’s 
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diagnosis including: monitoring of chronic conditions to assess for the development of 
complications and to provide rapid treatment and advice, to aid with treatment provisions 
(including providing cognitive behavioural therapy), for educational purposes in relation to self-
management, for specialist consultations and recommendations, for real-time monitoring, and for 
health care screening. 
Modalities utilized to deliver telemedicine services include videoconferencing, telephone 
contact, downloading glucose values, internet-based education, and connecting health care 
providers with patients separated by geographical distance (Giani & Laffel, 2016). Telemedicine 
was the original term used to identify health care services offered from a distance; however, as 
the popularity of telemedicine increased, the term telehealth was introduced to include a wider 
range of health-related functions including education and administration (Fatehi & Wootton, 
2012). A component of telehealth is mHealth which solely utilizes mobile technologies in a 
health care context and will be discussed in the following section. 
mHealth 
As the utilization of technology has exponentially increased in the past decade, much of 
the population now has access to a mobile phone or other type of portable electronic 
communication device at all times; such devices are capable of conducting tasks and functions 
not previously possible (Gagnon, Ngangue, Payne-Gagnon, & Desmartis, 2016). The 
International Telecommunications Union (2015) identified that at the end of 2015 there were 
more than 7 billion cellular subscriptions worldwide; in 2000, there were 730 million. However, 
mobile technologies are not limited to mobile phones; other types of mobile devices include: 
personal digital assistants, smartphones, portable media players, personal video-game consoles, 
and handheld and portable computers including tablets and laptops (Gagnon et al., 2016). The 
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functionality of mobile devices varies and can range from messaging, photo and video abilities, 
telephone and internet access, multimedia playback, tracking and location information, and 
software application support including the use of applications (apps) (Gagnon et al., 2016).  
According to Estrim and Sim, mHealth is recognized as “mobile communication devices, 
in conjunction with Internet and social media, [that] provide opportunities to enhance disease 
prevention and management by extending health interventions beyond the reach of traditional 
care” (2010, p. 759).  mHealth technology offers an unconventional method of addressing the 
challenges of chronic disease management by “enabling remote patient monitoring and delivery 
of clinical advice through a wide variety of functions (e.g. text messaging, web browsing, email, 
and videos)” (Kitsiou et al., 2017, para. 2). Furthermore, mHealth can promote health care 
prevention and health maintenance, aid in monitoring (both short-term and long-term), 
individualize health care to the specific needs of the patient, detect undesirable incidences and 
possible complications, and offer interventions and treatment (Varshney, 2005).  In the 
management of adolescents with T1DM, mHealth has the ability to track blood glucose and diet 
recordings, monitor physical activity, foster education, facilitate self-management and 
independence, augment patient-provider communication, identify possible complications and 
provide intervention as necessary, and enhance T1DM-related communication between 
parents/caregivers and adolescents (Kitsiou et al., 2017). One component of mHealth is 
applications which will be discussed in the following section. 
Applications. Applications (apps) are often a means of providing mHealth; apps are the 
software installed on a mobile device that can facilitate mHealth. In 2015 the IMS Institute for 
Healthcare Informatics reported that there are more than 165,000 health-related apps available 
for Apple iTunes and Android app stores (as cited in Misra, 2015). The function of health-related 
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apps varies considerably ranging from a basic reminder to apply sunscreen to more sophisticated 
apps aimed at managing chronic diseases (Boulos, Brewer, Karimkhani, Buller, & Dellavalle, 
2014). The diabetes mellitus epidemic is well-reflected in the number of apps available in the 
management of the chronic disease. Functions of diabetes-targeted apps vary, including: 
recording blood glucose measures, medication usage recordings (including insulin), and 
medication dosage calculators. Additionally, some apps can interface with providers as a way in 
which health information can be shared (for example, blood glucose recordings, dietary intake 
and physical activity) and to monitor adherence to chronic disease management regimens. Such 
interactive approaches can provide opportunity for health care professionals to create and adjust 
a patient’s plan of care; however, there are health care provider-related challenges in the 
literature related to time constraints, usability (i.e. difficulty integrating electronic medical 
records with apps and problems with overall workflow), resources (i.e. coverage outside of 
regular working hours), selection of an mHealth system (app) and compensation (Boulos et al., 
2014; Mallow et al., 2014; Gray et al.,2016; Gagnon et al., 2016). Since mHealth is highly 
accessible, Gagnon et al. (2016, para. 3) consider technology as a viable option for professionals 
in the primary care settings to engage with adolescents diagnosed with T1DM. However, 
incentives are often offered in research studies with the adolescent population and may be 
associated with increased usership of mHealth interventions (Afkinich & Blachman-Demner, 
2019). Furthermore, there is some association with usability and the inclusion of app end-users in 
the development and design phases; ideally, end-users are included in these phases (McCurdie et 
al., 2012).The following section will discuss the role of primary care providers. 
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Primary Care Providers 
Each day, thousands of Canadians visit a primary care provider (PCP) in Canada 
(Canadian Institute for Health Information [CIHI], 2017). PCPs providing primary care services 
include both nurse practitioners and family physicians (CIHI, 2017). Furthermore, the services 
provided by PCPs include: diagnosis; management; treatment and monitoring of acute/episodic 
and chronic diseases across the lifespan, mental health care, maternity and post-partum care, 
monitoring of child development, health promotion and disease prevention services, counseling, 
end-of-life care, referral to specialists and interdisciplinary team members, and minor procedures 
(CIHI, 2017; Government of Canada, 2012). Accessibility to a primary care provider and an 
individual’s choice to engage is often linked to the health status of an individual (Canadian 
Nurses Association [CNA], 2015; World Health Organization [WHO], 2019).  
The functionality of mHealth can influence health care interactions between patients and 
PCPs (Gagnon et al., 2016).The monitoring and communication components have capacity for 
direct patient benefit, including adherence, which may influence long term outcomes. For 
example, in a systematic review evaluating the effectiveness of mHealth in T1DM and T2DM, 
Kitsiou et al. (2017) identified that a reduction in HgbA1c was greater when there was a 
combination of text-messaging and Internet utilization for blood glucose monitoring in addition 
to clinical feedback. Thus, mHealth may increase monitoring and communication between a PCP 
and adolescent diagnosed with T1DM which may influence long term outcomes, including 
HgbA1c. The following section discusses family nurse practitioners in the context of primary 
care. 
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Family Nurse Practitioners  
Primary care providers include physicians and nurse practitioners in the province of 
British Columbia. Nurse Practitioners (NPs) were first introduced in British Columbia in 2005 
(British Columbia Nurse Practitioner Association [BCNPA], 2005). NPs practice as autonomous 
professionals providing care to both general and specialized groups, including: marginalized 
populations with substance use disorder and mental health conditions, seniors, individuals 
diagnosed with chronic diseases, and individuals with reproductive/women’s health concerns 
(Prodan-Bhalla & Scott, 2017). Additionally, NPs are working in acute care areas, including: 
trauma, nephrology, gastrointestinal, and cardiac care (Prodan-Bhalla & Scott, 2017, p.8).    
Nurse practitioners are regulated health care professionals who obtain additional 
advanced education in a graduate-level degree in order to diagnose and manage acute and 
chronic illnesses. NPs are regulated by the British Columbia College of Nursing Professionals 
[BCCNP], formerly the College of Registered Nurses of British Columbia or CRNBC. In British 
Columbia, the BCCNP (2018) identifies three streams to categorize areas of NP practice, 
including: family, adult, and pediatric. Family NPs have the knowledge and ability to provide 
care to individuals of all ages in primary care settings through the diagnosis, management, and 
treatment of acute/episodic and chronic conditions and health care screening (BCCNP, 2018). 
NPs utilize their background in nursing and acquire additional knowledge in health and human 
sciences to support the diverse needs of their chosen patient population stream. In this context, 
NPs have the scope of practice and appropriate knowledge and skills to manage T1DM in the 
adolescent population and may find benefit in utilizing mHealth for chronic disease management 
in clinical practice. 
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In summary, background information has been provided to offer context to the presented 
research question, including: the pathophysiology, clinical presentation, potential complications, 
HgbA1c and diagnostic criteria, and management of T1DM; adherence of adolescents with 
T1DM regimens; parental involvement in diabetic management; technology in health care and 
mHealth; and the role of PCPs. The following section will identify the search strategy that was 
utilized to obtain and analyze relevant literature to answer the research question. The 
conceptualization and preliminary search, focused search, and analysis phases will each be 
discussed in detail. 
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CHAPTER THREE: METHODS 
The objective of this integrative review was to determine if mHealth, when monitored by 
a primary care provider, can maintain hemoglobin A1c values in target range with adolescents 
between the ages of 10-19 with type 1 diabetes mellitus. The purpose of an integrative review is 
to analyze concepts in order to gain further understanding and contribute to evidence-based 
practice (Whittmore & Knafl, 2005). The quality of the methodology of an integrative review 
may impact the outcome of the posed research question; therefore, it is essential to conduct a 
focused, comprehensive literature search providing insight of how data was collected and the 
findings evolved. Providing transparency of the search process identifies possible bias and 
allows the reader to develop an understanding of the author’s progression through the literature 
(Whittmore & Knafl, 2005). The search strategy, including conceptualization and the preliminary 
search; the focused search; inclusion and exclusion criteria; and analysis will be discussed in the 
following section.  
Conceptualization and Preliminary Search 
 The conceptualization of this integrative review is based on five main concepts drawn 
from reviewing the background literature.  These include: the need for more stable metabolic 
control in adolescents diagnosed with T1DM, the interest that adolescents have in technology, 
mHealth as an evolving means of monitoring chronic diseases, the possibility of increasing 
accessibility for PCPs to contact patients and patients to contact PCPs, and an attempt reduce 
poor diabetic outcomes and complications associated with T1DM.  
An initial literature search was conducted in 2015 utilizing Google Scholar to explore the 
main concepts and connections between adolescence, T1DM, mHealth, and PCPs. Four 
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electronic databases were then selected to further explore the literature through the University of 
Northern British Columbia’s library: 
•! the Cumulative Index to Nursing and Allied Health Literature (CINAHL) complete, 
•! MEDLINE (Ovid)- the US National Library of Medicine’s database, 
•! the National Library of Medicine (PubMed), 
•! and Cochrane Reviews. 
The above databases were selected due to their relevance to health care. The primary search was 
undertaken in 2015, however the literature search was repeated in 2017 and again in 2018 to 
ensure up-to-date information could be reviewed as the author had taken a leave from her 
studies. Dates were limited from 2007 to 2018, in English, and peer-reviewed option-boxes were 
selected from databases when available; the peer-reviewed option was not an available option for 
the PubMed, MEDLINE, or Cochrane Reviews databases; however each article selected for this 
integrative review was peer-reviewed. 
 To ensure a comprehensive literature review was conducted, key terms and/or medical 
subject headings (MeSH) with appropriate truncation and wildcard functions were applied (see 
Table 1). The searches conducted that included the terms “primary care provider” and “primary 
health care” significantly narrowed the search resulting in zero publications. Modification to the 
search terms resulted in shifting away from ‘primary care provider’ to include language which 
included adolescence. The final search terms included: “adolescent OR adolescence” AND 
“diabetes mellitus, type 1 OR type 1 diabetes OR T1DM” AND “m?health OR mobile health OR 
mobile application”. In addition to formal academic databases, grey literatures were also 
reviewed. 
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More specifically, grey literature relevant to T1DM, mHealth, and PCPs was searched 
and yielded governmental data and reports from the Public Health Agency of Canada and 
provincial ministries, statistics from the WHO’s, policies and guidelines from the Diabetes 
Canada (formerly the Canadian Diabetes Association) and the Canadian Paediatric Society, and 
British Columbia College of Nursing Professional’s Scope of Practice for Nurse Practitioners 
document. Lastly, reference lists of publications from the leading researchers in the field of 
mHealth, T1DM, and adolescents were hand-searched ensuring relevant articles were retrieved 
and reviewed.  
Following the preliminary search, the writer developed a concept map to aid in the 
conceptualization process, differentiate between similar terms, and to identify connections 
amongst the terminology (see Appendix A). Burke et al recognize that “… [concept mapping] 
produces visual representations of the relationship between ideas, which provide unique insight 
into group thought and perspectives” (2005, p. 1408). Ultimately, the concept map process 
allowed the writer to confidently identify key terms to utilize in the search process, differentiate 
between key terms in the field of telemedicine, and make connections between search terms. 
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Table 1 
 
Search result combinations (conducted June 14, 2018) 
Focused Search 
All articles retrieved utilizing the search result combinations “1 AND 2 AND 3” in Table 
1 were then exported into the citation manager Zotero. “Primary Care Provider OR Primary Care 
OR Primary Healthcare (MeSH: Primary Health Care)” was removed as a primary search 
Boolean/MeSH Terms CINAHL PubMed 
(no peer 
review 
option) 
Medline 
(Ovid) 
(no peer-
review 
option) 
Cochrane 
Reviews (no 
peer-review 
option) 
1 Adolescent OR 
adolescence OR teen* 
 (MeSH: “adolescence”, 
“adolescent”) 
308,555 680,005 673,186 59,042 
2 diabetes mellitus, type 1 
OR type 1 diabetes OR 
T1DM (MeSH: “diabetes 
mellitus, type 1”) 
11,830 23,851 24,352 1,774 
3 m?health OR mobile 
health OR mobile 
application (MeSH: 
“telehealth”, 
“telemedicine”) 
4,072 15,112 14,421 2,212 
4 Primary care provider OR 
primary health care 
provider OR primary 
health care OR primary 
care (MeSH: “primary 
health care”) 
 
32,417 41,784 37,781 4,026 
1 AND 2 3,583 6,382 6,450 679 
1 AND 2 AND 3 7 43 37 11 
1 AND 2 AND 4 32 37 32 2 
1 AND 3 226 1129 1,108 244 
1 AND 4 3,296 5,843 5,176 567 
1 AND 2 AND 3 AND 4 0 1 1 0 
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component since the search yielded minimal results when combined with the other key search 
terms: adolescent, mHealth, and T1DM. Although a few of the articles included in the final 
literature selection do contain a primary care component or interaction with a health care 
professional, there was not enough relevant literature available to provide strong evidence to 
support or refute the research question. Therefore, the primary care component of the research 
question will be discussed further in the findings and discussion sections. 
Furthermore, duplicates were eliminated utilizing Zotero; additional duplicates that the 
citation management software did not identify were then removed during a hand-search. Titles 
and abstracts were then screened based on the inclusion and exclusion criteria identified in Table 
2. Upon completion of the title and abstract screen, 37 articles remained and were subjected to a 
full article review. Following the full article screen, application of the inclusion and exclusion 
criteria, and the removal of two articles as they were opinion papers with no methodology, five 
articles remained.  
Table 2 
Inclusion and exclusion criteria for the literature search 
Inclusion Criteria Exclusion Criteria 
-Focus on adolescent patients between the 
ages of 10-19 
-utilization of mHealth technology in the 
management of T1DM 
-Monitoring of HgbA1c 
-Published reports 
-Years of publication: 2007-2018 
-Publication language: English 
- Primary focus on adult and pediatric 
patient populations 
-Inpatient setting (i.e. acute care) 
- Blood glucose monitors as the sole 
mobile technology 
-Publications older than 10 years 
-Non-translated reports 
 
References of the remaining articles were also screened to identify relevant literature; one 
additional article was obtained increasing the total to six. See the PRISMA diagram (Figure 1) 
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for a visual aid of the search process. Following the review process, a literature matrix was 
created to assist the writer in organizing relevant data (See Appendix G). 
Figure 1 
 Search strategy and detailed results 
 
Analysis 
When reviewing the literature for the research question, a combination of both qualitative 
studies and quantitative studies presented. As quantitative data utilizes mathematical techniques 
for measurement in health care research, it can provide relevant data identifying if mHealth 
technology is effective in maintaining the HgbA1c of adolescents diagnosed with T1DM (Davies 
& Logan, 2012). The most prevalent quantitative data in this integrative review included 
statistics related to HgbA1c and participant demographics. However, there was also some 
qualitative data included in the research studies relevant to evaluating and understanding the 
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experiences and subsequent thoughts of adolescent patients (and their families) in relation to 
mHealth, although the qualitative data was limited. 
Furthermore, the literature review involved an analysis to examine reliability and 
credibility of each of the six articles selected.  The Joanna Briggs Institute Critical Appraisal 
Tools were then utilized to assist with this process and evaluate the strengths and limitations of 
each article. Specific tools included: the JBI Critical Appraisal Checklist for Systematic Reviews 
and Research Syntheses (Appendix B), the JBI Critical Appraisal Checklist for Quasi-
Experimental Studies (Appendix C), the JBI Critical Appraisal Checklist for Qualitative 
Research (Appendix D), and the JBI Critical Appraisal for Randomized Control Trials 
(Appendix E).  Lastly, a level of evidence rating was assigned to each article guided by the 
“quality of their design, validity, and applicability to patient care” (Winona State University, 
2019, para. 1). The descriptions of the various levels can be found in Appendix F. 
This integrative review, including thematic analysis, was guided by Whittemore and 
Knafl’s five stages, including: problem identification, the literature search, data evaluation, data 
analysis, and presentation (2005, p. 549). Upon analysis of the six articles through data display 
(creation of a literature matrix), four common themes emerged relevant to post-intervention 
HgbA1c, including: (1) research design factors (2) technological factors (3) participant factors, 
and (4) health care provider factors. These themes will be further discussed in the following 
findings section. 
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CHAPTER FOUR: FINDINGS 
An integrative review was conducted, including: a systematic search of the literature; 
collecting, reviewing and limiting relevant literature; creating a literature matrix; and finally 
analyzing, synthesizing, and reporting on the selected articles (Whittemore & Knafl, 2005). 
Through this process, six articles were selected to guide the research in answering the proposed 
question; one systematic review (Dougherty et al, 2014), one mixed-methods study (Frøisland et 
al., 2012), one randomized control trial (DiBartolo et al., 2017), and three quasi-experimental 
(non-randomized experimental) trials (Cafazzo et al., 2012; Carroll et al., 2011; Mulvaney et al., 
2012). The literature matrix in Appendix G provides details of the analysis of the articles 
selected for this integrative review, including an allocated level of evidence.  
Post-Intervention HgbA1c 
In each of the articles included in this review, HgbA1c which was used as an objective 
measurement to quantify the effectiveness of mHealth on glycemic control in adolescents. As 
HgbA1c is closely monitored in individuals diagnosed with T1DM, each of the selected studies 
made reference to these values in which the Diabetes Canada guidelines were utilized to identify 
a target range (Diabetes Canada, 2018). However, none of the selected articles in this integrative 
review provided strong evidence (p ≤ 0.05) for the use of mHealth in maintaining HgbA1c 
amongst the adolescent population. Pre-intervention HgbA1c values amongst the selected 
articles varied from 8.3 to 11.4% whereas the post-intervention HgbA1c range varied between; 
increased, reduced, and constant (unchanged) or between 8.1 and 9.79% as per Table 3 (Cafazzo 
et al., 2012; Carroll et al., 2011; Di Bartolo et al., 2017; Dougherty et al., 2012; Frøisland et al., 
2012; Mulvaney et al., 2012). Paired samples t tests were most commonly presented to 
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statistically compare pre and post-intervention HgbA1c values whereas independent t tests were 
calculated to compare HgbA1c values between intervention and control groups Table 3.  
Table 3 
Pre and post intervention HgbA1c values reporting SD where reported. 
 
Article Baseline HgbA1c 
(%) 
Post-intervention 
HgbA1c 
Difference in 
HgbA1c 
Cafazzo et al. (2012) 9.2 (SD 1.03) 8.8 (SD 0.74) -0.4% (p = .11) 
Carroll et al. (2011) 8.7 Self-reported (no 
values documented) 
N/A 
Di Bartolo et al. (2017) 10 (+/-1.4: 8.6-11.4) 9.66 (+/- 0.13: 9.53- 
9.79) at 6 months 
-0.50 (± 0.14%) 
(p = .51) 
Doughtery et al. (2012) *varied *varied *varied 
Frøisland et al. (2012) 8.3 (SD 0.9) 8.1 (SD 0.9) -0.2% (p = .38) 
Mulvaney et al. (2012) 8.8 (SD 2.1- control 
and intervention 
groups) 
8.8 (SD 2.3- control 
group; SD 2.1- 
intervention group) 
0 (p = .42) 
*= HgbA1c was presented for individual studies included in the review 
SD and p values were included as reported in selected articles  
 
While the answer to the questions of this integrative review is no— mHealth, when 
monitored by a PCP, does not help adolescents to maintain HgbA1c, other factors emerged for 
consideration that will be addressed in the discussion section. These include: (1) research design 
factors, (2) technological factors, (3) participant factors, and (4) health care provider factors. 
Each theme will be further explored in the following subsections.  
Research Design Factors 
 Two common themes that emerged during analysis related to research design included 
short intervention periods and small intervention (and control) group sizes. The length of the 
intervention period and the size of the intervention groups may have affected post-intervention 
HgbA1c values and will be further reviewed in the following sections. 
Short intervention periods. In order for interventional variations to influence HgbA1c, 
there must be an appropriate intervention time frame as HgbA1c tests long-term control of blood 
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glucose (accounting for approximately 100 to 120 days prior to the test) (Pagana et al., 2012).  A 
minimum amount of time for the interventional period was considered, although not included as 
an inclusion criterion for this integrative review as it would have significantly limited the number 
of studies available. The intervention period ranged from approximately three months or 100 to 
120 days (Cafazzo et al., 2012; Frøisland et al., 2012; Mulvaney et al., 2012) to six months or 
168 days (Carroll et al., 2011; Di Bartolo et al., 2017); each of the three mHealth-related studies 
included in Dougherty et al’s., systematic review were three months in length. Ultimately, a short 
intervention period (i.e. three to six months) limits recordable HgbA1c cycles using mHealth 
apps. Only having one-to-two cycles of HgbA1c measurement during the intervention period 
limits the collection of reliable data since HgbA1c levels can easily fluctuate when adolescents 
are managing their T1DM. Additionally, it may have taken users time at the beginning of a study 
to orientate to and become confident with using the apps. Small intervention group sizes were 
also identified as a research design factor that affected post-intervention HgbA1c values which, 
will be discussed in the following subsection. 
Small intervention group sizes. Overall the number of participants was small in 
comparison to the number of adolescents diagnosed with T1DM. Sample sizes between the 
studies varied significantly, from 12 participants (Carroll et al., 2011; Frøisland et al., 2012) to 
182 participants (Di Bartolo et al., 2017). Both Cafazzo et al. (2012) and Mulvaney et al. (2012) 
had between 20-28 participants. Small interventional groups can impact data; if a participant 
experiences significant changes to their HgbA1c in a small group, there is a chance that the 
average (or mean) value in the study could be misrepresented or hyper-inflated/deflated, 
therefore limiting generalizability. 
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Recognizing limitations in the studies is a critical aspect of an integrative literature 
review. Reporting factors which affect post-intervention HgbA1c values can influence future 
work in this area. Technological factors can also affect post-intervention HgbA1c values which 
will be reviewed in the following section. 
Technological Factors 
Each of the studies selected for this integrative review included a unique app designed for 
adolescents diagnosed with T1DM.  However, amongst the selected studies there were extensive 
variations amongst the apps’ functionality. In order to recognize factors that may have 
contributed to maintaining, improving, or worsening HgbA1c, better understanding of the apps is 
required. The following section will provide insight into app development and design, the 
variation in functionality of the apps, technological challenges, and orientation to the app that 
participants (and often their parents) experienced. 
App development and design. Providing the end-users with an opportunity to engage in 
the app development and design process may be associated with increased user ship of the app. 
Ideally, end-users are included in the development of an app to provide input for the end-
product; however this integrative review recognized that this is not routine practice for apps 
designed for adolescents diagnosed with T1DM.  
Inclusion of adolescents in the app design and development phases varied. Cafazzo et 
al.’s study collaborated with adolescents and their care providers (parents) during an extensive 
“user-centered design phase” (2012, p.4). Cafazzo et al. (2012) demonstrated the most inclusive 
end-user involvement during the development of their bant app. However, despite such 
inclusiveness there was no correlation with post-intervention HgbA1c in comparison to the other 
studies selected for this integrative review. 
 
 
39 
 For their SuperEgo intervention, Mulvaney et al. included “experts in diabetes adherence 
and clinical care, and adolescents with diabetes” in the design process (2012, p.115). However, 
Mulvaney et al. (2012) did not disclose if the adolescent participants in the design phase were 
diagnosed with T1DM, T2DM, or if participants included a combination of both; perhaps 
because they were considering testing SuperEgo with both adolescents with T1DM and 
adolescents with T2DM.     
Information relevant to the design and development of Carroll et al’s. Glucophone TM app, 
Di Bartolo et al’s. (2016) iBGStar TM + DMApp, and Frøisland et al’s. (2012) Diamob app were 
not provided. Additionally, Dougerty et al. (2014) did not include information regarding the 
development of the apps included in their systematic review. 
The development and design phase of an app targeted to be utilized by adolescents with 
T1DM would ideally involve adolescents diagnosed with T1DM, since they are the end-users. 
However, many of the studies included in this integrative review did not identify who was 
included in the early stages of design and development which questions if the targeted end-users, 
adolescents, were involved in the process and if outcomes of the included studies would have 
been different had adolescents been involved in the design and development process.  
Variation between apps. There were differences amongst the apps’ functionality, data 
management, monitoring parameters, and connectivity with the health care provider. Such 
differences pose challenges in the clinical setting as health care providers must be able to 
appraise, select, implement, and evaluate apps in order to utilize them with their patients. 
Furthermore, the variability in functionality of the apps creates a challenge when comparing the 
results between the studies. An overview of the apps included in each of the selected studies is 
presented in Table 4.  
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Table 4 
An Overview of Apps from the Selected Articles 
Study  mHealth App App function 
(Cafazzo et al., 
2012) 
 
bant -bant received information (blood glucose values) via Bluetooth 
technology from OneTouch UltraMini glucometers 
-Alerts provided to remind participants to check their blood glucose 
-Summaries of daily blood glucose values, meal and activity 
information, and highlights of out-of-range blood glucose values 
were provided 
-Gamification incentives (iTunes gift codes) were provided to 
encourage the participant to engage with the app 
-Participants were able to communicate amongst each other via a 
private group on Twitter 
(Carroll et al., 
2011) 
 
GlucophoneTM -Utilization of cell phone glucose monitoring (CPGM) transmitted 
SMBG values to a host computer which was monitored by a nurse 
practitioner (parents also had access to logs) 
-Additionally, GlucophoneTM provided the ability to communicate 
with a nurse practitioner (via phone or text message) 
(Di Bartolo et 
al., 2017) 
 
iBGStarTM -An app used in collaboration with iBGStarTM glucose meter 
-Blood glucose, HgbA1c, quality of life, and the number/type of 
interactions between the participants and the centre (assumed health 
care professional, although unidentified) were monitored; 
information collected was also downloaded during physician visits 
(Frøisland et 
al., 2012) 
 
Diamob and 
Diabetes 
Message 
System 
-Two mobile phone apps worked together to identify if the apps 
could impact T1DM disease management  
-The first app used photos in a diary manner to record physical 
activity and food consumption in addition to connecting with a 
glucometer via Bluetooth to track blood glucose values; the second 
app allowed for protected communication that utilized SMS 
technology to send messages to health care providers and 
participants 
(Mulvaney et 
al., 2012) 
 
SuperEgo -A combined mobile/web-based application targeted at motivating 
and reminding adolescents of diabetes-related tasks (i.e. SMBG) 
-Four functions were included in the intervention: assessment, 
message selection, message scheduling, and requests of messages 
from other participants; users selected the types of messages they 
wanted to receive (i.e. in relation to burn out/stress, sports/exercise, 
etc) in addition to timing and frequency 
-On average, each participant received 10 messages per week 
 
As evidenced in Table 6 the overall aim of the apps focused on improving glycemic 
control. The functionality of the apps varied considerably in addition to the presentation and 
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layout of the apps themselves. For example, several studies (Cafazzo et al., 2012; Carroll et al., 
2011; Di Batrolo et al., 2017; Mulvaney et al., 2012) prioritized SMBG in their apps and focused 
on sending reminders and alerts to participants to check their blood glucose several times a day. 
Whereas Frøisland et al. (2012) took a different approach and incorporated photography by 
having participants take a photo of their meal in addition to a pre and post prandial SMBG in 
order to visualize and connect how diet influences HgbA1c and insulin dosages. The differences 
in the functionality of the apps create challenges for use in the primary care setting. This point 
will be further explored in the provider section of the findings. 
Technological complications. As technology can fail, identifying potential technological-
related complications is imperative to mHealth interventions. Dependable and consistent 
technology is essential to not only keep participants engaged with mHealth and to reduce 
frustrations, but also to collect reliable data both clinically and in research. Despite some studies 
presenting several technological difficulties (i.e. connectivity in rural locations) (Carroll et al., 
2011; Frøisland et al. 2012), others experienced fewer difficulties (Cafazzo et al’s., 2012; 
Mulvaney et al., 2011). Of note, the outcomes across all studies were similar in terms of post-
intervention HgbA1c, despite technological challenges. 
App and device education/orientation. Selected studies provided education on apps 
function, system and ease of use.  Dougherty et al.’s review (2014) acknowledged that research 
studies which included an app compatible with a participant’s existent mobile device were user-
friendly. Meaning that, participants who were familiar with their own device and were not 
required to learn how to use an additional device were less likely to experience a device 
transition. 
 
 
42 
How education occurred varied across the studies; all noted training was necessary but 
details were not consistently provided. For example, Carroll et al. (2011) had a member of the 
research team sit-down with the adolescent and his or her parent/guardian and provide 
instruction. Alternatively, Mulvaney et al. (2012) had the adolescent engage in education through 
automated demonstration.  Furthermore, not all studies reported if parents attended app education 
sessions. Additionally, the amount of time allocated to provide app education to either 
participants or parents/caregivers was not present in any of the included studies. The following 
section discusses participant factors relevant to post intervention HgbA1c values in greater 
detail. 
Participant Factors 
 During the process of analysis, factors specifically related to the participant groups that 
potentially affected post-intervention HgbA1c were recognized. These included: demographics, 
incentives, and adherence.  
Participant demographics. Several of the articles included in this integrative review 
provided a variety of demographics specific to their participant population (Cafazzo et al., 2012; 
Carroll et al., 2011; Dougherty et al., 2014; Frøisland et al., 2012). The eligibility criteria for 
participants varied between studies, although several consistent demographics were reported 
including: a minimum amount of time diagnosed with T1DM, age range, the ability to read and 
write in English, HgbA1c within a specific range, and/or no additional underlying chronic 
diseases. Two thirds of the studies included minimal socioeconomic and/or background 
information of selected participants (Cafazzo et al., 2012; Carroll et al., 2011; Dougherty et al., 
2014; Frøisland et al., 2012) whereas one third collected a greater depth and range of 
demographic variables (Di Bartolo et al., 2016; Mulvaney et al., 2012). Comparison between 
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intervention group and control group was recorded succinctly by Di Bartolo et al., (2016) and 
included: age, gender, living status, educational and income, clinical disease history and 
outcome. 
Matching within studies aims to improve study efficiency by matching factors such as 
age. Quantitative approaches aim to improve precision in measurement and analysis meaning 
that results have greater transferability (Pearce, 2016). Typically, independent variables (the 
apps) affect the dependent variable (HgbA1c) with confounding factors affecting the 
independent variable. The only research team that matched their control group to their 
intervention group was Mulvaney et al. (2012); each group had thirteen males (57 percent), the 
average age of the intervention group was 15.9 years (15.8 in the control group), and the 
HgbA1c of participants in both groups was  8.9 percent. Furthermore, of the participants who 
finished the study, the average amount of time they had been diagnosed with diabetes was 7.9 
years, the median household income was $70,000-100,000 annually, and the average age for 
parental education was 14.3 years.  
Providing transparency relevant to patient demographics aids future researchers in better 
understanding of confounding variables, which may tailor future diabetes management for 
specific socio-economic groups. For example, there may be a connection between higher 
socioeconomic status and app usage amongst participants in the intervention groups as 
households with greater disposable income may have greater opportunity to purchase technology 
to be able to use apps in their daily lives.  
Incentives. Incentives, including access to technology, rewards and compensation, often 
motivate individuals to engage in a process or complete a specific task that he or she may have 
not otherwise considered. Incentives may have motivated adolescents to participate and engage 
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in the studies vs. the app itself (see Appendix G for details of incentives offered in the selected 
studies). Furthermore, only half of the studies (Cafazzo et al., 2012; Carroll et al., 2011; 
Frøisland et al., 2012) revealed how participants obtained a device for the duration of the study; 
of these studies, participants were loaned a smart phone or iPod Touch. 
Rewards for using the app were embedded within several studies; for example, the bant 
app had a complex gamification rewards algorithm whereby participants received points for 
adherence to best-practice guidelines for monitoring of their blood glucose (Cafazzo et al, 2012). 
Points were provided for each blood glucose test performed and bonus points were allocated for 
a full day of testing. Participants reported that the ease of attaining the rewards helped motivation 
since the rewards translated to redeemable vouchers i.e., Apple iTunes and App Store purchases 
(Cafazzo et al., 2012). Overall, Cafazzo et al. identified that an average of eight rewards per 
participant was distributed; five of twenty participants collected no rewards and ten percent of 
participants earned a high number of rewards (2012). Generally, if adolescents collected rewards 
at the start of the study, they continued accruing rewards until the end of the study. Some 
participants did not redeem their rewards which raises the question of the importance of 
incentives for all adolescents. In examining this against sociodemographic data it may have 
helped identify if motivation to engage in the study was linked to low social-economic status 
(SES). For example, adolescents from low SES may have enrolled in the study to access 
otherwise unaffordable monitoring equipment or mobile technology. 
Ethical guidelines within many countries outline the maximum financial reward available 
to participants. Therefore, remuneration of fifty dollars was applied in Carroll et al’s. (2011) 
pilot project, at three study points (at baseline, 3 months, and 6 months) adolescents received 
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$50. Similarly, Mulvaney et al. (2012) compensated participants although the amount was not 
disclosed.  
Interestingly, none of the studies included in this integrative review identified how 
incentives or reward approach was determined pre-study. Furthermore, ninety percent of the 
studies failed to explore participant satisfaction with the incentive or rewards program in the app.  
Adherence. Adherence was a recurrent theme that emerged amongst the selected studies 
and was most commonly measured by participant surveys or in terms of self-monitoring blood 
glucose (SMBG). Measuring adherence in the adolescent population using HgbA1c alone is 
ineffective due to physiological changes and other complex factors.  
The apps at times appeared to help the youth keep track of their self-care practices, which 
in turn likely influenced their HgbA1c. For example, Mulvaney et al. identified that their 
mHealth intervention assisted adolescent participants in “remembering to monitor blood glucose, 
packing supplies, reducing self-care procrastination, reduced feelings of isolation and 
embarrassment, and [by] bringing diabetes to ‘the front of my [the adolescent’s] mind’”  
suggesting that adherence was improved (2012, p. 117). However, there was no pre or post 
intervention survey or interview to determine the extent to which adherence improved.  
Adherence was linked to the ‘type’ of app and the creativity in its design. Apps that were 
able to invite youth to track and monitor their own progress were more successful even if they 
did not support primary care provider management. For example, Di Bartolo et al. (2014) 
identified adherence to SMBG monitoring as one of two main objectives in their study 
determining if their iBGStar TM + DMApp apps were superior to traditional blood-glucose 
monitoring systems. Adherence of SMBG was first assessed two weeks prior to the intervention 
period by obtaining recorded SMBG data; similar data was then obtained after the intervention 
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period was complete. Investigators measured and defined adherence in three ways: (1) as a 
dichotomous variable (i.e. occurrence of SMBG ≥30% vs <30% of the recommended frequency), 
(2) by the average amount of SMBG conducted weekly, (3) and by “percent compliance” defined 
as the number of tests performed in comparison to the number of tests prescribed by the 
adolescent’s PCP (Di Bartolo et al., 2014, p. 395). Adherence was again assessed six months 
following the conclusion of the intervention period which represented Di Bartolo et al’s. (2014) 
primary end points; after six months, 53.6% of individuals in the  iBGStar TM + DMApp group 
and 55.0% of individuals in the control group had enhanced SMBG monitoring. While not 
statistically significant, this supports future study in the area of treatment satisfaction and self-
care behaviours. Despite evidence of improvements in self-care practices during the intervention 
periods, long-term adherence and HgbA1c outcomes remain unknown.  
 Often self-care is a primary consideration linked to patient outcomes. For example, 
Cafazzo et al. (2014) measured treatment adherence by conducting a 14 item “Self-Care 
Inventory” pre and post-intervention survey. The Self-Care Inventory was a self-assessment tool 
on a scale of 1 (never do it) to 5 (always do this as recommended without fail) (Cafazzo et al., 
2014). The Self-Care Inventory did not identify significant changes to pre and post-intervention 
results; the pre-intervention average score was 3.5 (SD 0.93) whereas the post-intervention 
average score was 3.6 (SD 0.93) (Cafazzo et al., 2014). However, it should be noted that results 
from the Self-Care Inventory assessment may be open to bias and they may not capture the 
patient experiences that are currently influencing self-care.  
 Similar to Cafazzo et al. (2014), Carroll et al. conducted a self-reported survey using an 
agree and disagree questionnaire to assess “Adolescent-Reported Activities and Feelings About 
the Glucophone TM”. Sixteen percent of adolescent participants agreed that they increased the 
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frequency of SMBG as a result of participating in the study (Carroll et al., 2011). However, as 
the study was self-reported, results need to be considered with caution since the time points to 
collect data are open to variables such as youth mood, motivation, and other wider factors.  
 Adherence is a complex factor that is well studied within primary care work. Therefore, 
the role the primary care provider has in T1DM monitoring, using an app or other approach, is 
influenced by factors that are attributed to adherence and self-management. The following 
section will discuss health care provider factors. 
Health Care Provider Factors  
 This integrative review was based on the idea that mHealth monitoring by a primary care 
provider could maintain HgbA1C in adolescents between 10-19 years. However, not all studies 
in this review included a primary care provider in their study. This section will discuss the 
inclusion of a primary care provider in relevant studies in addition to barriers to mHealth 
implementation in practice. 
Inclusion of a primary care provider. The study by Carroll et al., (2011) engaged a nurse 
practitioner (NP) as the primary care provider within a multi-disciplinary team approach. The 
role of the NP was valued by the study participants yet did not directly influence HgbA1c 
outcomes. The term ‘value’ was not defined in the post-intervention participant survey, however 
adolescents in Carroll et al.’s (2011) study associated value with accessibility to an NP for 
chronic disease management support. Communication aspects of the apps were used in studies, 
such as the messaging the provider, however impact on maintaining HgbA1c levels was not 
significant (Frøisland et al., 2012).  Therefore, despite increasing accessibility and engagement 
with a health care provider (Carroll et al, 2011; Di Bartolo et al., 2012; Frøisland et al., 2012), 
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increased accessibility was not linked to improved HgbA1c. Meaning, there was no correlation 
between time spent engaged with a health care provider and improved or better outcomes. 
However, adolescent participants did identify that they appreciated and valued increased 
access to health care providers. While there was no statistical evidence that health care provider 
accessibility maintained HgbA1c, there was weak evidence conducted through a post-
intervention participant survey to suggest that adolescent-provider interactions reminded 
adolescents to practice self-care (i.e. SMBG) (Carroll et al., 2011). Despite mHealth not having 
an effect on post-intervention HgbA1c in this integrative review, there are factors to consider if 
mHealth was implemented into the practice setting. 
Barriers to mHealth implementation in practice. Many health care providers are currently 
limited by time due to patient demands, a heavy workload, and a national primary care provider 
shortage in Canada (Malko & Huckfeldt, 2017; Statistics Canada, 2019). When considering 
mHealth as a means to engage patients and monitor chronic disease, workload and feasibility 
must be considered. Carroll et al. disclosed that the NP in their study spent an average of two-
hours per day communicating with participants regarding flags which included “blood glucose 
patterns that needed to be addressed to reduce potential acute and chronic problems” (2011, 
p.61). On average two hours per day were spent updating charts, clinical notes, and dose 
adjustments while the NP spent an hour in the evening communicating further to adolescents’ 
responses (Carroll et al., 2011). For this reason, Carroll et al. (2011) questioned mHealth’s 
feasibility since the NP in their study worked outside of their normal clinical hours.  
Although Frøisland et al. (2012) included two physicians from an outpatient clinic who 
were responsible for responding to messages from adolescent participants via the Diamob app, 
they did not indicate the amount of hours per day that the PCPs spent engaging with participants 
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via Diamob or if the physicians were compensated for their time. Like Frøisland et al. (2012), Di 
Bartolo et al. (2017) identified that participants made contact with health care professionals at 
the diabetes centre, however they too did not identify the amount of time that health care 
professionals were spending contacting participants or if they (the health care professionals) 
were compensated. Di Bartolo et al. (2017) did acknowledge that their iBGStarTM intervention 
increased the amount of contact between patients and the diabetes clinic; however they 
concluded that an increase in contact resulted in increased health care expenditures questioning 
the feasibility of an mHealth intervention.  
Dougherty et al. recognized that studies which combined the utilization of technology 
with parental and heath care provider involvement were more successful than those that did not 
(2014). However, Dougherty et al. further identified that clinicians spent time counseling 
patients, ordering lab work, and adjusting medications via mHealth platforms which was not 
financially compensated for (2014). Additionally, Dougherty et al. (2014) noted that no 
intervention from their selected studies was compatible with an electronic health records which 
would promote provider efficiency; often interventions required multiple logins and manual data 
entry requiring significant effort. Increased workload from an mHealth initiative without a means 
for financial compensation would likely result in disinterest from primary care providers; 
furthermore, the inability for apps to “communicate” with electronic health records and multiple 
logins could result in provider frustration which would likely lead to dis-engagement from 
providers. From the studies, the amount of time health care providers needed to understand and 
apply mHealth was not disclosed. While workload may not directly influence maintaining 
HgbA1c value, implementing apps in practice requires significant knowledge and time 
commitment on the part of the primary care provider. 
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An mHealth intervention is not well-supported from a feasibility and workload point-of-
view. Furthermore, compensation, regulation, on-call schedules, etc were negligibly discussed 
which would only add to costs. The following section will discuss implications for future clinical 
practice, research, and education. 
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CHAPTER FIVE: DISCUSSION 
The following section focuses on synthesizing key findings, including: research design 
factors, technological factors, participant factors, and health care provider factors. The objective 
of this integrative review was to explore if mHealth, when monitored by a primary care provider, 
could support adolescents with T1DM in maintaining HbgA1c levels; however, as the findings 
did not support the original hypothesis, it is not recommended. Although, the evidence did 
uncover considerations for future research and exploration that will be presented here.  
Research Design Factors 
 During analysis of the selected articles, there were two main considerations identified 
relevant to the studies’ research design. These considerations include: short intervention periods 
and small intervention group sizes which will be further discussed in the following subsections 
(Cafazzo et al., 2012; Carroll et al., 2011; Di Bartolo et al., 2017; Dougherty et al., 2014; 
Frøisland et al., 2012; Mulvaney et al., 2012). 
Short Intervention Periods  
Short interventions periods, i.e. three to six months, limited opportunity for adolescents 
and health care providers to become familiar with an app and restricted the amount of data 
available to collect due to the limited number of HgbA1c cycles (Cafazzo et al., 2012; Carroll et 
al., 2011; Di Bartolo et al., 2017; Dougherty et al., 2014; Frøisland et al., 2012; Mulvaney et al., 
2012). Furthermore, as adolescents are situated within a phase of critical development and 
subsequently, they do not prioritize their health due to compelling psychosocial demands 
(Cafazzo et al., 2012; Carroll et al., 2011; Di Bartolo et al., 2017; Dougherty et al., 2014; 
Frøisland et al., 2012; Mulvaney et al., 2012; WHO, 2017). Therefore, while the combination of 
short intervention periods and app use may help adolescents focus on specific T1DM-related 
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tasks, using an app to monitor longer term trends of hard endpoints, such as HbgA1c stability, is 
burdensome for many adolescents. Additional factors that may inhibit longer intervention 
periods include: time pressures from research studies, challenges engaging adolescents for long 
periods of time, and participant or parental commitment concerns (Cafazzo et al., 2012; Carroll 
et al., 2011; Di Bartolo et al., 2017; Dougherty et al., 2014; Frøisland et al., 2012; Mulvaney et 
al., 2012). It is therefore recommended to increase the duration of studies related to mHealth and 
HgbA1c monitoring of adolescents diagnosed with T1DM over more than one-to-two HgbA1c 
cycles. 
Small Intervention Group Sizes 
 Small sample sizes may have been a result of challenges with the recruitment process or a 
limited population to select participants from (Cafazzo et al., 2012; Carroll et al., 2011; Di 
Bartolo et al., 2017; Frøisland et al., 2012; Mulvaney et al., 2012). Additionally, adolescents 
diagnosed with T1DM may not see value in an app making them less inclined to volunteer as 
participants. Furthermore, as there are many apps available to adolescents, they may be less 
interested in participating due to app fatigue. As adolescents are ‘busy’ individuals the extra time 
demand from a research study may be bothersome or an inconvenience. Lastly, small 
intervention group size also limits generalizability which affects the ability to apply the study 
results to a larger population.  
 Including adolescent participants in research studies is challenging for a range of reasons. 
Parrish, Duron, and Oxhandler (2017) recognize barriers to recruitment with adolescents such as 
the complexities of consent and developing cognitive ability and maturity. As adolescents are in 
the midst of physiological and psychological growth, adolescent maturity is an issue amongst 
each of the selected studies (Cafazzo et al., 2012; Carroll et al., 2011; Di Bartolo et al., 2017; 
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Dougherty et al., 2014; Frøisland et al., 2012; Mulvaney et al., 2012). In order to reduce 
research- based recruitment-related challenges in the adolescent population, Grape et al. (2018) 
suggest the following: follow-up with the potential adolescent of their parent/caregiver as soon 
as possible after initial contact, focusing on parental engagement and potentially offering an 
incentive for participation, using multiple methods of communication (i.e. email, text, phone), 
etc. A combination of the approaches outlined by Grape et al. (2018) were not clearly reported in 
the reviewed studies only isolated approaches, including incentives and multiple methods of 
communication (Cafazzo et al., 2012; Carroll et al., 2011; Mulvaney et al., 2012).  
 Furthermore, small sample sizes limit generalizability. Generalizability is defined as “the 
extension of research findings and conclusions from a study conducted on a sample population to 
the population at large. While the dependability of this extension is not absolute, it is statistically 
probable.” (University of Colorado, 2020, para. 2). However, seeking larger intervention group 
sizes may not be the ultimate answer. Moving away from a quantitative approach towards 
qualitative research study designs can influence knowledge outputs which in turn can shape and 
guide practice. For example, Yates and Leggett recognize that “qualitative studies are 
appropriate for examining relationships between and among variables, describing trends, 
attitudes, or opinions of a population, as well as for testing the effects of a treatment or 
intervention on an outcome” (2016, p. 225) which could address some of the current challenges. 
Qualitative research studies would have a stronger emphasis on the experiences and meaning that 
adolescents have towards the utilization of mHealth in T1DM management. Future research 
relevant to mHealth with adolescents would benefit from considering a qualitative research 
designs, mixed method approached or larger intervention group sizes. The following section will 
discuss technological factors. 
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Technological Factors  
 Technological factors relevant to the use of mHealth with adolescents will be discussed 
in the following section. Such factors include app development and design and technological 
challenges relevant to app use in the clinical setting. 
App Development and Design 
Only one third of the articles selected in this integrative review identified modeling a 
user-centred approach during the development and design phase (Cafazzo et al., 2012; Mulvaney 
et al., 2012). A user-centred design “involves the user at every stage of the design process” 
which has been shown to add value to technology and ultimately increase usage (McCurdie et 
al., 2012, p. 50). The benefits of user-engagement are clear from the literature resulting in 
increased technology usability and a patient-focused application.  Failure to pay attention to 
involving adolescents can result in poor interest and refusal to use the app ultimately leading to 
wasted time and development costs (Farinango et al, 2018). The evidence in this review found it 
would be beneficial to include a user-centred approach during the development and design phase 
of apps used by adolescents diagnosed with T1DM. If adolescents are ultimately the population 
that will engage with the app, it would be beneficial to include them during the development and 
design phases.   
Technological Challenges 
When utilizing technology, hardware and software challenges can hinder usability and 
provide frustration for the user. Subsequently, technological challenges can affect the outcome of 
a research study applying mHealth. For example technology failure or poor connectivity could 
limit user interface resulting in frustration and disengagement while negatively impacting the 
study outcome. Although there were technological challenges noted in the selected articles, the 
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time span of these challenges was not documented; furthermore, there were no technological 
failures reported (Cafazzo et al., 2012; Carroll et al., 2011; Frøisland et al. 2012; Mulvaney et al., 
2011). Depending on the extent of a technological failure and how mHealth technology is being 
used, patient safety could be compromised. Based on the evidence reviewed, it is recommended 
that future research explore mHealth back-up strategies. 
Participant Factors 
Many factors were recognized relevant to participants in the selected studies, including 
patient demographics, incentives, and adherence. These factors will be synthesized in the 
following section. 
Participant Demographics  
Limited demographic reporting in the studies raised questions of equity and diversity. 
Race, household income, family size, marital status of participant’s parents or guardians, etc. 
were infrequently presented, although Di Bartolo et al. (2016) and Mulvaney et al. (2012) did 
present a greater detail of demographic information in comparison to the other articles. 
Robinson, McMichael, and Hernandez suggest that recognizing diversity provides a better 
understanding of a group’s health behaviours, quantifies and monitors outcomes, and reduces 
disparities meaning that demographic reporting can result in greater insight while eliminating 
bias (2017, p. 263).  
As there has been a substantial amount of attention paid to information and 
communications technology and access inequalities, it would be beneficial to include these data 
in research studies (Zhong, 2010, p. 736). For example, adolescents’ socioeconomic status is 
linked to family income; if a family’s income is low, the ability to purchase and sustain 
information technology (i.e. internet connection, app purchases, hardware purchases) is 
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prohibitive. The evidence related to patient demographics supports three recommendations 
related to research.   
1.! Intervention periods should expand over more than one-to-two HgbA1c cycles. 
2.! Increased number of participants in sample sizes or exploration of qualitative research 
designs or mixed method approaches in mHealth-related studies. 
3.! Participant demographics, including socioeconomic status (household income, level of 
parental education, race, ethnicity, etc.), be presented in the research. 
Incentives 
 Although incentives may engage adolescents to participate in research studies, they 
question the long-term feasibility of the intervention if participants are motivated solely by the 
incentive (Carroll et al., 2011; Cafazzo et al., 2012; Mulvaney et al., 2012). Grant and Sugarman 
state that “incentives are one of the various ways in which people can get other people to do what 
they want them to do” and although there is a relationship with power, incentives are most often 
recognized as a form of trade (2010, p. 721). With this idea, the sustainability of mHealth is 
questioned as it is not feasible to continuously offer mHealth users an incentive. Additionally, 
who would offer and fund an incentive for mHealth users? Furthermore, the use of incentives to 
increase adolescent participation is challenging as usership may increase, however it is 
challenging to recognize genuine interest in an app vs. participation related to the incentive 
(Grape et al., 2018). The evidence generated within this integrative review suggests that any 
incentive offered or provided to adolescent participants be clearly identified in the research 
studies. 
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Adherence 
The findings revealed that there was some evidence to suggest the use of mHealth for 
improvement to adherence. Adherence amongst adolescents diagnosed with T1DM is complex 
and multifaceted. Although adherence was mentioned in each article selected for this integrative 
review, Cafazzo et al. (2012) and Di Bartolo et al. (2017) were the only researchers that closely 
monitored adherence through self-assessment surveys and pre and post-intervention statistics 
related to SMBG. As a relationship between adherence to SMBG and a reduction in HgbA1c was 
identified, future research studying the use of mHealth with adolescents diagnosed with T1DM 
should shift focus to the relationship between mHealth and adherence using HgbA1c as a 
subsequent or secondary endpoint (Di Bartolo et al., 2017). Therefore, it is recommended that 
future research involving mHealth, adolescents, and T1DM include a means of assessing pre and 
post-intervention adherence. The following section will discuss health care provider factors. 
Health Care Provider Factors 
 Several factors were identified relevant to clinical practice that should be addressed prior 
to the implementation of mHealth in the clinical setting, including: health care provider 
education for app appraisal and selection supports, the primary care provider role in mHealth, 
and provider compensation and on-call scheduling. 
Health Care Provider Education for App Appraisal and Selection 
Not only does variation amongst apps and devices necessitate education and orientation 
for adolescents, primary care providers and students utilizing mHealth would also benefit from 
orientation and education to mHealth applications (Cafazzo et al., 2012; Carroll et al., 2011; Di 
Bartolo et al., 2017; Doughery et al., 2014; Frøisland et al., 2012; Mulvaney et al., 2012). The 
risk of a health care provider not understanding the quality of an app may compromise patient 
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safety (Canadian Medical Association [CMA], 2015). If a primary care provider chose to 
implement mHealth into their clinical setting to augment traditional chronic disease 
management, or if a patient requests to engage in mHealth, there are several factors that need to 
be considered relevant to provider education. The CMA (2015) created a document, “Guiding 
Principles for Physicians Recommending Mobile Health Applications to Patients”, which is 
targeted towards physicians to assist in the assessment of and clinical application of apps. In 
addition to having identified that the app is safe and relevant to patient use, a summary of the 
CMA recommends: ensuring that the app is endorsed by a professional association, medical 
society, or health care organization; identifying if and when the app requires software updates 
and recognizing that the app has been time-stamped by the developer at the time of the last 
update; assessing if the patient has the technological skills to engage with mHealth; informing 
patients about security risks about mHealth and technology in health care; and recommending 
apps that have endured validation testing (2015). Each of these recommendations from the CMA 
(2015) requires a minimum level of knowledge; however it is uncertain where and how providers 
are to obtain the relevant knowledge to support the safe implementation of apps in the clinical 
setting.  
One example of an organization that aids in assessment of health-related apps is the 
United Kingdom’s Organisation for the Review of Care and Health Applications [ORCHA]. 
ORCHA evaluates health apps across Europe, the Middle East, Africa, the Americas, and Asia 
(ORCHA, 2018). ORCHA, or a similar interface, may provide a solution in assisting primary 
care providers in assessment and recommendation of apps. However, an interface such as 
ORCHA does hold challenges for primary care providers, including time; the utilization of 
ORCHA may reduce accessibility for patients to their primary care providers as providers need 
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time to research the evaluation of health apps. Furthermore, ORCHA has a complex funding 
model with support from government organizations including the National Health Service, 
accreditation services offered, hospitals, universities, professional licensure, etc. (ORCHA 
Health LTD, 2020). Such interfaces may be costly; although ORCHA does not currently have an 
associated fee for health care providers, this may not be the case in the future. Although ORCHA 
is one option, reviewing possible systems to aid primary care providers in selecting apps for 
clinical use is beyond the scope of this integrative review. With numerous chronic disease 
management apps available, a clear and well-defined process must be established in order for 
primary care providers (including those who are less technologically inclined) to implement 
mHealth into clinical practice. For this reason, it is recommended that guidelines or policies be 
made available to assist primary care providers in app selection for use in the clinical setting. 
The Primary Care Provider Role and Organizational Issues in mHealth 
 The primary care provider role in chronic disease management is pivotal in long-term 
outcomes of patients (WHO, 2019). Working with adolescents can be challenging for primary 
care providers yet they have a role in diagnosis, management, treatment and monitoring of acute 
and chronic diseases; education; and supportive psychosocial development (CIHI, 2017; 
Government of Canada, 2012). When a health care provider or primary care provider was 
included in the selected studies, participants valued their support and availability (Carroll et al., 
2011; Frøisland et al., 2012). However, often primary care providers are part of a team approach 
working with adolescents diagnosed with T1DM. Therefore, it is recommended that roles of the 
interdisciplinary team be further explored to determine who is the most appropriate and cost-
effective member to monitor an mHealth intervention (Carroll et al., 2011; Frøisland et al., 
2012).  
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 Furthermore, despite participants valuing the presence of a primary care provider or 
health care provider, organizational matters require consideration, including on-call availability 
and compensation. Primary care providers have traditionally been required to offer on-call 
services for health-related issues (Ministry of Health, 2019). Therefore, based on the evidence, it 
is recommended that on-call schedules and compensation models undergo review when 
integrating mHealth into clinical practice. The following section will conclude this integrative 
review. 
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Conclusion 
 The prevalence of diabetes has been on the rise in recent years. Subsequently, the amount 
of diabetes-associated health care expenditure has increased. According to the Government of 
Canada, approximately 3 million Canadians (8.1%) were living with diagnosed diabetes (T1DM 
or T2DM) during 2013-2014 amounting to 1 in 300 youth between the ages of 1 and 19 and 1 in 
10 adults over the age of 20 (Government of Canada, 2017). By 2026, the Government of 
Canada predicts that the prevalence of diabetes will increase affecting 14 million Canadians with 
a cost of five billion dollars annually (2017). As adolescents with T1DM traditionally are often 
above their glycemic target and non-adherent to treatment regimens, there is value in exploring 
unconventional treatment adjuncts, such as mHealth. 
Guided by the research question, this integrative review explored the literature, identified 
four common themes from the findings relevant to post-intervention HgbA1c, and synthesized 
the findings in the discussion section. Although this integrative review does not support the use 
of mHealth, when monitored by a PCP, to maintain HgbA1c in target range with adolescents 
between the ages of 10-19 diagnosed with T1DM, recommendations for clinical practice, 
research, and policy were identified and are presented in Table 4.  
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Table 4  
Summary of Recommendations for Clinical Practice, Education, and Future Research 
Recommendations for Clinical Practice 
Recommendation Supporting Evidence 
•! The use of mHealth with adolescents in 
clinical practice to maintain HgbA1c, when 
monitored by a primary care provider, is not 
supported by the current evidence 
•! Cafazzo et al., 2012; Carroll et al., 2011; Di 
Bartolo et al., 2017; Doughery et al., 2014; 
Frøisland et al., 2012; Mulvaney et al., 2012 
•! Guidelines and policies be made available to 
assist primary care providers in app selection 
for use in the clinical setting 
•! Cafazzo et al., 2012; Carroll et al., 2011; Di 
Bartolo et al., 2017; Doughery et al., 2014; 
Frøisland et al., 2012; Mulvaney et al., 2012 
•! On-call systems and compensation models for 
primary care providers relevant to mHealth be 
reviewed and implemented into practice  
•! Cafazzo et al., 2012; Carroll et al., 2011; Di 
Bartolo et al., 2017; Doughery et al., 2014; 
Frøisland et al., 2012; Mulvaney et al., 2012 
Recommendations for Education 
Recommendation Supporting Evidence 
•! Education relevant to app selection and 
utilization  in clinical practice be implemented 
for primary care providers and students 
•! Cafazzo et al., 2012; Carroll et al., 2011; Di 
Bartolo et al., 2017; Doughery et al., 2014; 
Frøisland et al., 2012; Mulvaney et al., 2012 
Recommendations for Future Research 
Recommendation Supporting Evidence 
•! Intervention periods of studies including 
mHealth and HgbA1c expand over more than 
one-to-two HgbA1c cycles 
•! Cafazzo et al., 2012; Carroll et al., 2011; Di 
Bartolo et al., 2017; Frøisland et al., 2012; 
Mulvaney et al., 2012 
•! An increase to the number of participants in 
sample sizes or exploration of qualitative 
research designs or mixed method approaches 
in mHealth-related studies 
•! Cafazzo et al., 2012; Carroll et al., 2011; Di 
Bartolo et al., 2017; Frøisland et al., 2012; 
Mulvaney et al., 2012 
•! Disclosure of participant demographics 
(including: household income, level of 
parental education, race, ethnicity, etc.) in 
mHealth-related research studies 
•! Di Bartolo et al., 2017; Mulvaney et al., 2012 
•! Inclusion of end-users in app design and 
development phases 
•! Cafazzo et al., 2012;  Mulvaney et al., 2012 
•! Acknowledgement of incentives offered and 
provided to adolescent research participants 
•! Cafazzo et al., 2012; Carroll et al., 2011; Di 
Bartolo et al., 2017; Doughery et al., 2014; 
Frøisland et al., 2012; Mulvaney et al., 2012 
•! Measurement of adherence pre and post 
mHealth intervention documented  
•! Cafazzo et al., 2012; Di Bartolo et al ., 2017 
•! Exploration of the most appropriate health 
care provider to engage in mHealth with 
adolescents 
•! Carroll et al., 2011; Di Bartolo et al., 2017; 
Frøisland et al., 2012 
•! Exploration of technological back-up 
strategies for mHealth in clinical practice 
•! Cafazzo et al., 2012; Frøisland et al., 2012 
 
 
63 
References 
Al-Agha, A., Ocheltree, A., & Hakeem, A. (2011). Metabolic control in children and adolescents 
with insulin-dependent diabetes mellitus at. Journal of Clinical Research in Pediatric 
Endocrinology, 3(4), 202–207. http://doi.org/10.4274/jcrpe.415 
 
Afkinich, J. L., & Blachman-Demner, D. R. (2019). Providing incentives to youth participants in 
research: A literature review. Journal of Empirical Research on Human Research Ethics. 
https://doi.org/10.1177/1556264619892707 
 
American Association for Clinical Chemistry. (2018). Islet autoantibodies in diabetes. Retrieved 
from https://labtestsonline.org/tests/islet-autoantibodies-diabetes 
 
American Diabetes Association. (2018). Children and adolescents: Standards of medical care in 
diabetes—2018. Diabetes Care, 41(Supplement 1), S126-S136. 
 
American Psychological Association. (2002). Developing adolescents: A reference guide for 
professionals. Retrieved from http://www.apa.org/pi/families/resources/develop.pdf 
 
Anderson, M. & Jiang, J. (2018). Teens, social media & technology 2018. Retrieved from 
http://www.pewinternet.org/2018/05/31/teens-social-media-technology-2018/ 
 
Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014). Type diabetes. Lancet, 383(9911), 
69–82. doi: 10.1016/S0140-6736(13)60591-7 
 
Atkinson, M. A., von Herrath, M., Powers, A. C., & Clare-Salzler, M. (2015). Current concepts 
on the pathogenesis of type 1 diabetes—Considerations for attempts to prevent and reverse 
the disease. Diabetes Care, 38(6), 979-988. 
 
Balasubramanian, K., Dabadghao, P., Bhatia, V., Colman, P. G., Gellert, S. A., Bharadwaj, U., ... 
& Bhatia, E. (2003). High frequency of type 1B (idiopathic) diabetes in North Indian children 
with recent-onset diabetes. Diabetes Care, 26(9), 2697-2697. 
 
Barton, A. J. (2012). The regulation of mobile health applications. BMC medicine, 10(1), 46. 
 
BC Children’s Hospital. (2016). Transition timeline brochure. Retrieved from 
http://www.bcchildrens.ca/our-services/support-services/transition-to-adult-care 
 
Berg, C. A., King, P. S., Butler, J. M., Pham, P., Palmer, D., & Wiebe, D. J. (2011). Parental 
involvement and adolescents’ diabetes management: The mediating role of self-efficacy and 
externalizing and internalizing Behaviors. Journal of Pediatric Psychology, 36(3), 329–339. 
http://doi.org/10.1093/jpepsy/jsq088 
 
 
 
64 
Bilandzic, A., & Rosella, L. (2017). The cost of diabetes in Canada over 10 years: Applying 
attributable health care costs to a diabetes incidence prediction model. Chronic Diseases and 
Injuries in Canada, 37(2). 
 
Borus, J. S., & Laffel, L. (2010). Adherence challenges in the management of type 1 diabetes in 
adolescents: Prevention and intervention. Current opinion in pediatrics, 22(4), 405. 
 
Boulos, M. N. K., Brewer, A. C., Karimkhani, C., Buller, D. B., & Dellavalle, R. P. (2014). 
Mobile medical and health apps: State of the art, concerns, regulatory control and 
certification. Online Journal of Public Health Informatics, 5(3), 229. 
http://doi.org/10.5210/ojphi.v5i3.4814 
 
Brashers, V. L., Jones, R. E., & Huether, S. E. (2014). The endocrine system- Alterations of 
hormonal regulation. In K. L. McCance & S. E. Huether (Eds.), Pathophysiology- The 
biologic basis for disease in adults and children (pp. 717-767).  St. Louis, MO: Elsevier. 
 
Brazeau, A. S., Nakhla, M., Wright, M., Panagiotopoulos, C., Pacaud, D., Henderson, M., ... & 
Dasgupta, K. (2016). Stigma and its impact on glucose control among youth with diabetes: 
Protocol for a Canada-wide study. JMIR Research Protocols, 5(4). 
 
British Columbia College of Nursing Professionals. (2018). Scope of practice for nurse 
practitioners. Retrieved from https://www.bccnp.ca/Standards/RN_NP 
/StandardResources/NP_ScopeofPractice.pdf 
 
British Columbia Ministries of Health, Education, and Children and Family Development. 
(2015). Provincial standards: Supporting students with type 1 diabetes in the school setting. 
Retrieved from http://www2.gov.bc.ca/assets/gov/education/administration/kindergarten-to-
grade-12/healthyschools/diabetes/diabetes_support_in_school_settings.pdf 
 
Burke, J. G., O’Campo, P., Peak, G. L., Gielen, A. C., McDonnell, K. A., & Trochim, W. M. 
(2005). An introduction to concept mapping as a participatory public health research method. 
Qualitative Health Research, 15(10), 1392-1410. 
 
Butner, J., Berg, C. A., Osborn, P., Butler, J. M., Godri, C., Fortenberry, K. T., … Wiebe, D. J. 
(2009). Parent-adolescent discrepancies in adolescents’ competence and the balance of 
adolescent autonomy and adolescent and parent well-being in the context of type 1 
Diabetes. Developmental Psychology, 45(3), 835–849. doi: 10.1037/a0015363 
 
Caferoğlu, Z., İnanç, N., Hatipoğlu, N., & Kurtoğlu, S. (2016). Health-related quality of life and 
metabolic control in children and adolescents with type 1 diabetes mellitus. Journal of 
Clinical Research in Pediatric Endocrinology, 8(1), 67–73. doi: 10.4274/jcrpe.2051 
 
Cafazzo, J. A., Casselman, M., Hamming, N., Katzman, D. K., & Palmert, M. R. (2012). Design 
of an mHealth app for the self-management of adolescent type 1 diabetes: A pilot 
study. Journal of Medical Internet Research, 14(3), e70. http://doi.org/10.2196/jmir.2058 
 
 
65 
 
Canadian Diabetes Association. (2018). Diabetes statistics in Canada. Retrieved from 
http://www.diabetes.ca/how-you-can-help/advocate/why-federal-leadership-is 
-essential/diabetes-statistics-in-canada 
 
Canadian Diabetes Association Clinical Practice Guidelines Expert Committee [CDACPGEC]. 
Canadian diabetes association 2013 clinical practice guidelines for the prevention and 
management of diabetes in Canada. Canadian Journal of Diabetes 2013; 37(suppl 1): S1-
S212. Retrieved from http://guidelines.diabetes.ca/fullguidelines 
 
Canadian Institute for Health Information. (2017). Primary health care. Retrieved from 
https://www.cihi.ca/en/primary-health-care 
 
Canadian Medical Association. (2015). Guiding principles for physicians recommending mobile 
health applications to patients. Retrieved from https://www.cma.ca/sites/default/files/2018 
-11/cma_policy_guiding_principles_for_physicians_recommending_mobile_health 
_applications_to_patients_pd1-e.pdf 
 
Canadian Nurses Association. (2015). Primary health care. Retrieved from https://cna 
-aiic.ca/~/media/cna/page-content/pdf-en/primary-health-care-position-statement.pdf?la=en 
 
Canadian Paediatric Society. (2016). Age limits and adolescents. Retrieved from https://www 
.cps.ca/en/documents/position/age-limits-and-adolescents 
 
Carroll, A. E., DiMeglio, L. A., Stein, S., & Marrero, D. G. (2011). Using a cell phone-based 
glucose monitoring system for adolescent diabetes management. The Diabetes 
Educator, 37(1), 59-66. 
 
Carroll, A. E., Marrero, D. G., & Downs, S. M. (2007). The HealthPia GlucoPack™ diabetes 
phone: a usability study. Diabetes Technology & Therapeutics, 9(2), 158-164. 
 
Chiang, J. L., Maahs, D. M., Garvey, K. C., Hood, K. K., Laffel, L. M., Weinzimer, S. A., ... & 
Schatz, D. (2018). Type 1 diabetes in children and adolescents: A position statement by the 
American Diabetes Association. Diabetes Care, 41(9), 2026-2044. 
 
Coffen, R. D. (2009). The 600-step program for type 1 diabetes self-management in youth: The 
magnitude of the self-management task. Postgraduate medicine, 121(5), 119-139. 
 
Contact. (2019). In Cambridge Dictionary online. Retrieved from 
https://dictionary.cambridge.org/dictionary/english/contact  
 
Datye, K. A., Moore, D. J., Russell, W. E., & Jaser, S. S. (2015). A review of adolescent 
adherence in type 1 diabetes and the untapped potential of diabetes providers to improve 
outcomes. Current Diabetes Reports, 15(8), 51. doi:10.1007/s11892-015-0621-6 
 
 
 
66 
Davies, B. & Logan, J. (2012). Reading research: A user-friendly guide for health professionals 
(5th ed.). Toronto, ON: Elsevier. 
 
Diabetes Canada. (2018). Clinical practice guidelines. Retrieved from 
https://guidelines.diabetes.ca/cpg 
 
Diabetes Control and Complications Trial Research Group. (1995). The relationship of glycemic 
exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes 
control and complications trial. Diabetes, 44(8), 968-983. 
 
Diabetic Children’s Foundation. (2018). T1DM and T2DM. Retrieved from https://www 
.diabetes-children.ca/en/type-1-diabetes/t1d-t2d/ 
 
Di Bartolo, P., Nicolucci, A., Cherubini, V., Iafusco, D., Scardapane, & M., Rossi, M. (2017). 
Young patients with type 1 diabetes poorly controlled and poorly compliant with self-
monitoring of blood glucose: Can technology help? Results of the i-NewTrend randomized 
clinical trial. Acta Diabetologica, 54(4), 393–402. 
 
Distiller, L. A. (2014). Why do some patients with type 1 diabetes live so long?. World journal 
of Diabetes, 5(3), 282. 
 
Donner, T., Champaneri, S., Saudek, C. (2015). Autoantibodies in type 1 diabetes. Johns 
Hopkins Diabetes Guide. Retrieved from https://labtestsonline.org/tests/islet-autoantibodies-
diabetes 
 
Donner, T. (2015). Insulin–pharmacology, therapeutic regimens and principles of intensive 
insulin therapy. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK278938/ 
 
Dougherty, J. P., Lipman, T. H., Hyams, S., & Montgomery, K. A. (2014). Telemedicine for 
adolescents with type 1 diabetes. Journal of Nursing Research, 36(9), 1199–1221. 
https://doi.org/10.1177/0193945914528387 
 
Dunbar-Jacob, J., & Mortimer-Stephens, M. (2001). Treatment adherence in chronic 
disease. Journal of Clinical Epidemiology, 54(12), S57-S60. 
    
Estrin, D. & Sim, I. (2010). Open mHealth architecture: An engine for health care 
innovation. Science, 330(6005), 759-760. 
 
European Patients’ Academy. (2018a). Hard endpoint. Retrieved from https://www.eupati.eu 
/glossary/hard-endpoint/ 
 
Farinango, C. D., Benavides, J. S., Cerón, J. D., López, D. M., & Álvarez, R. E. (2018). Human-
centered design of a personal health record system for metabolic syndrome management 
based on the ISO 9241-210:2010 standard. Journal of Multidisciplinary Healthcare, 11, 21–
37. doi:10.2147/JMDH.S150976 
 
 
67 
 
Fatehi, F. & Wootton, R. (2012). Telemedicine, telehealth or e-health? A bibliometric analysis of 
the trends in the use of these terms. Journal of Telemedicine and Telecare, 18(8), 460-464. 
doi: 10.1258/jtt.2012.GTH108 
 
Flodgren, G., Rachas, A., Farmer, A. J., Inzitari, M., & Shepperd, S. (2015). Interactive 
telemedicine: Effects on professional practice and health care outcomes. The Cochrane 
Library. 
 
Frøisland, D. H., Årsand, E., & Skårderud, F. (2012). Improving diabetes care for young people 
with type 1 diabetes through visual learning on mobile phones: Mixed-methods study. Journal 
of Medical Internet Research, 14(4). 
 
Gagnon, M. P., Ngangue, P., Payne-Gagnon, J., & Desmartis, M. (2016). m-Health adoption by 
healthcare professionals: A systematic review. Journal of the American Medical Informatics 
Association, 23(1), 212-220. 
 
Gandhi, K., Vu, B. M. K., Eshtehardi, S. S., Wasserman, R. M., & Hilliard, M. E. (2015). 
Adherence in adolescents with Type 1 diabetes: Strategies and considerations for assessment 
in research and practice. Diabetes Management, 5(6), 485. 
 
Garrity, V. (2017). Tweens, teens, and technology:  The risks and the benefits. The Association 
for Child and Adolescent Mental Health. Retrieved from https://www.acamh.org/blog/tweens-
teens-technology-risks-benefits/ 
 
Giani, E. & Laffel, L. (2016). Opportunities and challenges of telemedicine: Observations from 
the wild west in pediatric type 1 diabetes. Diabetes Technology & Therapeutics,18(1), 1-3. 
 
Government of Alberta. (2020). Glycohemoglobin (HgbA1c, A1c). Retrieved from 
https://myhealth.alberta.ca/Health/Pages/conditions.aspx?hwid=hw8432 
 
Government of Canada. (2012). About primary health care. Retrieved from https://www 
.canada.ca/en/health-canada/services/primary-health-care/about-primary-health-care.html 
 
Government of Canada. (2017). Diabetes in Canada. Retrieved from https://www.canada.ca/en 
/public-health/services/publications/diseases-conditions/diabetes-canada-highlights-chronic-
disease-surveillance-system.html#box1 
 
Grant, R. W. & Sugarman, J. (2010). Ethics in human research: Do incentives matter. Journal of 
Medicine and Philosophy, 29(6), 717-738. 
 
Grape, A., Rhee, H., Wicks, M., Tumiel-Berhalter, L., & Sloand, E. (2018). Recruitment and 
retention strategies for an urban adolescent study: Lessons learned from a multi-center study 
of community-based asthma self-management intervention for adolescents. Journal of 
Adolescence, 65, 123–132. https://doi.org/10.1016/j.adolescence.2018.03.004 
 
 
68 
 
 
 
Gray, C. S., Gill, A., Khan, A. I., Hans, P. K., Kuluski, K., & Cott, C. (2016). The electronic 
patient reported outcome tool: Testing usability and feasibility of a mobile app and portal to 
support care for patients with complex chronic disease and disability in primary care 
settings. Journal of Medical Internet Research, 4(2), e58.  
 
Hamine, S., Gerth-Guyette, E., Faulx, D., Green, B. B., & Ginsburg, A. S. (2015). Impact of 
mHealth chronic disease management on treatment adherence and patient outcomes: A 
systematic review. Journal of Medical Internet Research, 17(2), e52. 
 
HealthLinkBC. (2018). Glycohemoglobin (HbA1c, A1c). Retrieved from 
https://www.healthlinkbc.ca/medical-tests/hw8432 
 
Herge, W. M., Streisand, R., Chen, R., Holmes, C., Kumar, A., & Mackey, E. R. (2012). Family 
and youth factors associated with health beliefs and health outcomes in youth with type 1 
diabetes. Journal of Pediatric Psychology, 37(9), 980–989. http://doi.org/10.1093/jpepsy 
/jss067 
 
Horne, R., Weinman, J., Barber, N., Elliott, R., Morgan, M., Cribb, A., & Kellar, I. (2005). 
Concordance, adherence and compliance in medicine taking. London, EN: NCCSDO, 2005, 
40-6. 
 
International Telecommunications Union. (2015). ICT facts and figures: The world in 2015. 
Retrieved from https://www.itu.int/en/ITU-D/Statistics/Documents/facts 
/ICTFactsFigures2015 .pdf 
 
Jeha, G. S. & Haymond, M. W. (2016). Clinical features and diagnosis of diabetic ketoacidosis 
in children. In J. I. Wolfsdorf & A. G. Hoppin (Eds.), UpToDate. Waltham, Mass.: 
UpToDate. Retrieved from www.uptodate.com 
 
Joanna Briggs Institute. (2017a). Checklist for systematic reviews and research syntheses. 
Retrieved from http://joannabriggs.org/assets/docs/critical-appraisal-tools/JBI_Critical 
_Appraisal-Checklist_for_Systematic_Reviews2017.pdf 
 
Joanna Briggs Institute. (2017b). Checklist for quasi-experimental studies. Retrieved from 
http://joannabriggs.org/assets/docs/critical-appraisal-tools/JBI_Quasi-Experimental 
_Appraisal_Tool2017.pdf 
 
Joanna Briggs Institute. (2017c). Checklist for qualitative research. Retrieved from 
http://joannabriggs.org/assets/docs/critical-appraisal-tools/JBI_Critical_Appraisal-
Checklist_for_Qualitative_Research2017.pdf 
 
 
 
69 
Joanna Briggs Institute. (2017d). Checklist for randomized control trials. Retrieved from 
http://joannabriggs.org/assets/docs/critical-appraisal-tools/JBI_RCTs_Appraisal_tool2017.pdf 
 
Johnson, M. (2015). The online lives of Canadian youth. The Vanier Institute of the Family. 
Retrieved from https://vanierinstitute.ca/online-lives-canadian-youth/ 
 
Juarez, D., Goo, R., Tokumaru, S., Sentell, T., Davis, J., & Mau, M. (2013). Association between 
sustained glycated hemoglobin control and healthcare costs. The American Journal of 
Pharmacy Benefits, 5(2), 59–64. 
 
Kalyani, R. R. (2017). Diagnosis and classification of diabetes. John Hopkins  Diabetes Guide. 
Retrieved from https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes 
_Guide/547038/all/Diagnosis_and_Classification_of_Diabetes 
 
Kitsiou, S., Paré, G., Jaana, M., & Gerber, B. (2017). Effectiveness of mHealth interventions for 
patients with diabetes: An overview of systematic reviews. Public Library of Science 
One, 12(3), e0173160. doi: 10.1371/journal.pone.0173160 
 
Lenhart, A. (2015). Teens, social media & technology: Overview 2015. Retrieved from 
http://www.pewinternet.org/2015/04/09/teens-social-media-technology-2015/ 
 
Litmanovitch, E., Geva, R., & Rachmiel, M. (2015). Short and long term neuro-behavioral 
alterations in type 1 diabetes mellitus pediatric population. World Journal of Diabetes, 6(2), 
259–270. http://doi.org/10.4239/wjd.v6.i2.259 
 
Malko, A. V., & Huckfeldt, V. (2017). Physician shortage in Canada: A review of contributing 
factors. Global Journal of Health Science, 9(9), 68-80. 
 
Mallow, J.A., Theeke, L. A., Barnes, E. R., Whetsel, T., & Mallow, B. K. (2014) Using mHealth 
tools to improve rural diabetes care guided by the chronic care model. Online Journal of 
Rural Nursing & Health Care, 14(1), 43-65. doi:10.14574 /ojrnhc.v14i1.276 
 
Marshall, M., Carter, B., Rose, K., & Brotherton, A. (2009). Living with type 1 diabetes: 
Perceptions of children and their parents. Journal of Clinical Nursing, 18(12), 1703-1710. 
 
Masharani, U. (2016). Diabetes mellitus & hypoglycemia. In M. A. McCance & S. J. McPhee 
(Eds.). Current-Medical diagnosis and treatment (pp. 1190-1248).  United States of America: 
McGraw-Hill. 
 
McCurdie, T., Taneva, S., Casselman, M., Yeung, M., McDaniel, C., Ho, W., & Cafazzo, J. 
(2012). mHealth consumer apps: The case for user-centered design. Biomedical 
Instrumentation & Technology, 46(s2), 49-56. 
 
Medical Dictionary. (2017). In Merriam Webster online. Retrieved April 18, 2017, from 
https://medlineplus.gov/mplusdictionary.html 
 
 
70 
 
Metzger, D. L. (2010). Diabetic ketoacidosis in children and adolescents: an update and revised 
treatment protocol. BC Medical Journal, 52, 24-31. 
 
 
Ministries of Health, Education and Children and Family Development. (2015). Provincial 
standards: Supporting students with type 1 diabetes in the school setting. Retrieved from 
http://www.bcchildrens.ca/SHHC-Your-Visit-Site/Documents/Supporting_Students_with 
_Type_1 _Diabetes _School_Setting.pdf 
 
Misra, R. (2015). New report finds more than 165,000 mobile health apps now available, takes 
close look at characteristics & use. Retrieved from 
http://www.imedicalapps.com/2015/09/ims-health-apps-report/ 
 
Moawad, G. E., & Ebrahem, G. G. S. (2016). The relationship between use of technology and 
parent-adolescents social relationship. Journal of Education and Practice, 7(14), 168-178. 
 
Moore, S. M., Hackworth, N. J., Hamilton, V. E., Northam, E. P., & Cameron, F. J. (2013). 
Adolescents with type 1 diabetes: Parental perceptions of child health and family functioning 
and their relationship to adolescent metabolic control. Health and Quality of Life 
Outcomes, 11, 50. http://doi.org/10.1186/1477-7525-11-50 
 
Mulvaney, S. A., Anders, S., Smith, A. K., Pittel, E. J., & Johnson, K. B. (2012). A pilot test of a 
tailored mobile and web-based diabetes messaging system for adolescents. Journal of 
Telemedicine, 18(2), 115–118. https://doi.org/10.1258/jtt.2011.111006 
 
Nathan, D. M. (2014). The diabetes control and complications trial/epidemiology of diabetes 
interventions and complications study at 30 years: Overview. Diabetes Care, 37(1), 9-16. 
 
National Health Service. (2017). Diabetic ketoacidosis. Retrieved from 
https://www.nhs.uk/conditions/diabetic-ketoacidosis/ 
  
ORCHA Health LTD. (2020). ORCHA- Digital health products & services. Organisation for the 
Review of Care and Health-Related Apps. 
 
Organisation for the Review of Care and Health Applications. (2018). About us. Retrieved from 
https://www.orcha.co.uk/about-us/ 
 
Pagana, K. D., Pagana, T. J., & Pike-MacDonald, S. A. (2012). Mosby's Canadian Manual of 
Diagnostic and Laboratory Tests. Milton, ON: Elsevier Canada. 
 
Papadakis, M. A., & McPhee, S. J. (Eds.). (2016). CURRENT medical diagnosis and treatment. 
New York, NY: McGraw Hill.  
 
 
 
71 
Paschou, S. A., Papadopoulou-Marketou, N., Chrousos, G. P., & Kanaka-Gantenbein, C. (2018). 
On type 1 diabetes mellitus pathogenesis. Endocrine Connections, 7(1), R38-R46. 
 
Paterick, T. E., Patel, N., Tajik, A. J., & Chandrasekaran, K. (2017). Improving health outcomes 
through patient education and partnerships with patients. Proceedings, 30(1), 112. 
 
Pearce, N. (2016). Analysis of matched case-control studies. British Medical Journal, 352, i969. 
 
Prodan-Bhalla, N. & Scott, L. (2017). Primary care transformation in British Columbia: A new 
model to integrate nurse practitioners. British Columbia Nurse Practitioner Association. 
Retrieved from https://bcnpa.org/wp-content/uploads/BCNPA_PHC_Model_FINAL          
-November-2-2016.pdf 
 
Provincial Health Services Authority. (2017). Diabetes. Retrieved from 
http://www.bcchildrens.ca/health-info/coping-support/diabetes 
 
Public Health Agency of Canada. (2011). Diabetes in Canada: Facts and figures from a public 
health perspective. Retrieved from http://www.phac-aspc.gc.ca/cd-mc/publications/diabetes        
-diabete/facts-figures-faits-chiffres-2011/pdf/facts-figures-faits-chiffres-eng.pdf 
 
Robinson, J. K., McMichael, A. J., & Hernandez, C. (2017). Transparent reporting of 
demographic characteristics of study participants. JAMA Dermatology, 153(3), 263-264. 
 
Saberzadeh-Ardestani, B., Karamzadeh, R., Basiri, M., Hajizadeh-Saffar, E., Farhadi, A., 
Shapiro, A. J., ... & Baharvand, H. (2018). Type 1 Diabetes Mellitus: Cellular and molecular 
pathophysiology at a Glance. Cell journal, 20(3), 294-301. 
 
Skinner, H., Biscope, S., Poland, B., & Goldberg, E. (2003). How adolescents use technology for 
health information: implications for health professionals from focus group studies. Journal of 
Medical Internet Research, 5(4), e32. 
 
Smaldone, A., Steiner, R., & Whittemore, B. (2017). Endocrine and metabolic disorders. In C. E. 
Burns, A. M. Dunn., M. A. Brady., N. B. Starr, C. G. Blosser, & D. L. Garzon (Eds.), 
Pediatric primary care (6th ed., pp. 596-625). St. Louis, MO: Elsevier. 
 
Smith, J., Cheater, F., & Bekker, H. (2015). Parents' experiences of living with a child with a 
long!term condition: A rapid structured review of the literature. Health Expectations, 18(4), 
452-474. 
 
Statistics Canada. (2019). Primary health care providers, 2017. Retrieved from 
https://www150.statcan.gc.ca/n1/pub/82-625-x/2019001/article/00001-eng.htm 
 
Taddeo, D., Egedy, M., & Frappier, J.-Y. (2008). Adherence to treatment in 
adolescents. Paediatrics & Child Health, 13(1), 19–24. 
 
 
 
72 
US National Library of Medicine. (2018). Osmotic diuresis. Retrieved from 
https://medlineplus.gov/ency/article/001266.htm 
 
Varshney, U. (2005). Pervasive healthcare: applications, challenges and wireless 
solutions. Communications of the Association for Information Systems, 16(1), 3. 
 
van de Kar, E., & Den Hengst, M. (2009). Involving users early on in the design process: 
Closing the gap between mobile information services and their users. Electronic 
Markets, 19(1), 31-42. 
 
Viswanathan, M., Golin, C. E., Jones, C. D., Ashok, M., Blalock, S. J., Wines, R. C., ... & Lohr, 
K. N. (2012). Interventions to improve adherence to self-administered medications for chronic 
diseases in the United States: A systematic review. Annals of Internal Medicine, 157(11), 
785-795. 
 
 
Venes, D. (Ed.). (2001). Taber’s cyclopedic medical dictionary. Philadelphia, PA: FA Davis. 
 
Wallander, J. L., & Varni, J. W. (1998). Effects of pediatric chronic physical disorders on child 
and family adjustment. Journal of Child Psychology and Psychiatry, 39(1), 29-46. 
 
Watanabe, J. H., McInnis, T., & Hirsch, J. D. (2018). Cost of prescription drug–related morbidity 
and mortality. Annals of Pharmacotherapy, 52(9), 829-837. 
 
Wherrett, D., Huot, C., Mitchell, B., & Pacaud, D. (2013). Diabetes Canada clinical practice 
guidelines 2013: Type 1 diabetes in children and adolescents. Retrieved from 
http://guidelines.diabetes.ca/browse/chapter34 
 
Wherrett, D., Ho, J., Huot, C., Legault, L., Nakhla, M., & Rosolowsky, E. (2018). 2018 Clinical 
practice guidelines: Type 1 diabetes in children and adolescents. Canadian Journal of 
Diabetes, 42(Suppl 1), S234-246. 
 
Whittemore, R., & Knafl, K. (2005). The integrative review: Updated methodology. Journal of 
Advanced Nursing, 52(5), 546-553. doi:10.1111/j.1365-2648.2005.03621.x 
 
Winona State University. (2019). Evidence based practice toolkit. Retrieved from 
https://libguides.winona.edu/c.php?g=11614&p=61584 
 
World Health Organization. (2003). Adherence to long-term therapies: Evidence for action. 
Retrieved from http://www.who.int/hiv/pub/prev_care/lttherapies/en/ 
 
World Health Organization. (2010). Telemedicine: Opportunities and developments in member 
states. Retrieved from http://www.who.int/goe/publications/goe_telemedicine_2010.pdf 
 
 
 
73 
World Health Organization. (2017). Adolescent development. Retrieved from 
http://www.who.int/maternal_child_adolescent/topics/adolescence/development/en/ 
 
World Health Organization. (2019). Primary health care. Retrieved from  
https://www.who.int/news-room/fact-sheets/detail/primary-health-care 
 
You, W. P., & Henneberg, M. (2016). Type 1 diabetes prevalence increasing globally and 
regionally: The role of natural selection and life expectancy at birth. BMJ Open Diabetes 
Research & Care, 4(1), 1-7. doi: 10.1136/bmjdrc-2015-000161 
 
Zhong, Z. J. (2011). From access to usage: The divide of self-reported digital skills among 
adolescents. Computers & Education, 56(3), 736-746. 
 
 
74 
APPENDICES 
Appendix A  
Concept Map 
 
!
!
!
!
!
!
!
!
!
!
!
!
!
! !
!
!
!
!
!
!
!
! !
!
!
!
!
!
!
! !
CAPSTONE!PROJECT!
CONCEPT!ANALYSIS:!
KEY!TERMS!
Telehealth'
!!Delivery!of!healthcare!services!
Distance!
!Interaction!(provider(s)/patients)!
(See!Patient'Provider'Interaction)!
Provider.to.provider'
+/.'patient3'patient'to'
provider'w/'tele.
monitoring'
!
Telecommunications!
Adolescence'
Period'of'significant'
growth'and'development'
Risk.taking'
Ages'10.19'
Family'Nurse'
Practitioner'
(as'Primary'Care'
Provider)'
Context)'
Advanced'
practice'nurse'
Regulated'
by'CRNBC'
Nursing'background'
with'additional'
'health'sciences'and'
medicine'knowledge'
Primary'Health''
Care'Provider/'
Primary'Care'
Provider'
Provider'
General'
practitioner'
Family'
physician'
Health'care'
services'
Diagnosis,'treatment,'and'
management'of'episodic'and'
chronic'health'conditions'
Mental'health'
care'
Maternity'and'post.
partum'care'
Health'promotion/screening'
and'disease/injury'prevention'
services'
Referral'to'specialist'
physicians'and'interdisciplinary'
team'members'
Counselling'
End'of'life'care'
Minor'
procedures'
Monitoring'of'child'
development'
Accessibility'
and'health'status'
correlation'
Risk'
Adherence/'
Nonadherence'
Patient'
behaviou
r/beliefs'
Prognosis'
Medical'advice'
Treatment'effectiveness'
Health'care'provider'(see'
patient'provider'
interaction)'
Potential'or'probability'
Disease'
Injury' Harm'
Death'
Desired'
Outcomes'
Outcomes'
Poor'outcomes'
Undesired'
Good'
outcomes'
Poor'Control'
Failure'to'follow'
Complicat.
ed'by'
growth/'
develop.'
ment3'see'
adolesce.
nce'
Patient'Provider'
Interaction'
Good'
patient/provider'
interaction'
Patient/'
provider'
frustrati.
on'
Condition/'
disease'
education'
Patient'
empowerment'
Managem
ent'of'
mental'
health'
conditions'
Family/'peer'support' Limited'education'on'
condition/disease/'
result'of'poor'
adherence'
Poor'family/peer'support'
Poor'management'
of'mental'health'
conditions'
Non.
adhere
nce'
Side'
effects'
!
Mis.
diagn
osis'
Patient'
optimism'
Measure.
ment'
Hard'
Soft'
Effective''
Communication'
Friendliness/'
approachability'
Patient.centred'
care'
Holistic'care'
Active'listening'
Partnership'
Trust'
Poor'
patient/'
provider'
interaction'Ineffective'
Poor'
demeanor'
Lack'of'
trust'
Power.
over'
approach'
Un.holistic'
care'
Patient'autonomy'
Lack'of'
patient'
autonomy'
Health'literacy' Reduced'
Undesirable'
Chronic'
disease'
Health'screening'
See!outcomes'
Disease/disorder/Co.'
ndition'recognition'
Reduction'of'
complications'
Improved'health'
status'
Early'
treatment'
mHealth!
Complications'
Health'assessment'
State'of'difficulty'
Increased'risk'
of'morbidity'and'
mortality'
Unwanted'or'
unintended'
Secondary'
disease'or'
condition'
Technology'
!
Evaluation/'
Analysis'
Mobile/wireless'
device'
Mobile'phones'
(smartphones/'
personal'digital'
assistant'phones)'
!
Handheld'
video.
game'
console'
Personal'
digital'
assistant'
Poor'disease'
trajectory'
Improvement'in'
health'status'
Health'
Assessment/'
Screening'
!
Secondary'prevention'
Poor'underst.
anding'of'
correlation'
between'
actions/'
consequences'
Tablet'
Telemedicine'
Telecommunications'
Clinical'
diagnosis/monitoring'
Applications'(apps)'
Physical'exam'
Health'history'
Health'care'provider'
(see'Primary'care'
provider)'
Data'collection'
 
 
75 
Appendix B  
JBI Critical Appraisal Checklist for Systematic Reviews and Research Syntheses 
!
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JBI Critical Appraisal Checklist for Quasi-Experimental Studies  
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Appendix D 
JBI Critical Appraisal Checklist for Qualitative Research 
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JBI Critical Appraisal Checklist for Randomized Controlled Trials 
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23.! Was!allocation!to!treatment!groups!concealed?! □! □! □! □!
24.! Were!treatment!groups!similar!at!the!baseline?! □! □! □! □!
25.! Were!participants!blind!to!treatment!assignment?! □! □! □! □!
26.! Were!those!delivering!treatment!blind!to!treatment!assignment?!! □! □! □! □!
27.! Were!outcomes!assessors!blind!to!treatment!assignment?! □! □! □! □!
28.! Were!treatment!groups!treated!identically!other!than!the!intervention!of!
interest?! □! □! □! □!
29.! Was!follow!up!complete!and!if!not,!were!differences!between!groups!in!
terms!of!their!follow!up!adequately!described!and!analyzed?! □! □! □! □!
30.! Were!participants!analyzed!in!the!groups!to!which!they!were!randomized?! □! □! □! □!
31.! Were!outcomes!measured!in!the!same!way!for!treatment!groups?! □! □! □! □!
32.! Were!outcomes!measured!in!a!reliable!way?! □! □! □! □!
33.! Was!appropriate!statistical!analysis!used?! □! □! □! □!
34.! Was!the!trial!design!appropriate,!and!any!deviations!from!the!standard!RCT!
design!(individual!randomization,!parallel!groups)!accounted!for!in!the!
conduct!and!analysis!of!the!trial?!
□! □! □! □!
!
Overall!appraisal:!! Include!!□! Exclude! !!□! Seek!further!info!!□!
Comments!(Including!reason!for!exclusion)!
(JBI, 2017d) 
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Appendix F 
Level of Evidence 
Level of evidence (LOE) Description 
Level I Evidence from a systematic review or meta-analysis of all 
relevant RCTs (randomized controlled trial) or evidence-based 
clinical practice guidelines based on systematic reviews of RCTs 
or three or more RCTs of good quality that have similar results. 
Level II Evidence obtained from at least one well-designed RCT (e.g. 
large multi-site RCT). 
Level III Evidence obtained from well-designed controlled trials without 
randomizations (i.e. quasi-experimental). 
Level IV Evidence from well-designed case-control or cohort studies. 
Level V Evidence from systematic reviews of descriptive and qualitative 
studies (meta-synthesis). 
Level VI Evidence from a single descriptive or qualitative study. 
Level VII Evidence from the opinion of authorities and/or reports of expert 
committees. 
(Ackley, Swan, Ladwig, & Tucker as cited in Winona State University, 2019) 
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Appendix G 
Literature Matrix 
 
Author/Title/Overview/Design Strengths Limitations Significant Findings 
(Cafazzo et al., 2012) 
 
Title:  Design of an mHealth App 
for the Self-management of 
Adolescent Type 1 Diabetes: A 
Pilot Study 
 
Quasi-experimental (non-
randomized experimental)/pilot 
study. 
 
Level of Evidence: Level III 
 
N= 20 
 
Adolescents (ages 12-16 years; 
mean 14.9) diagnosed with 
T1DM and their caregivers were 
interviewed and data was 
collected to inform the production 
of a mobile application, Bant. 15 
participants provided with an 
iPhone 4 and 5 participants were 
provided with an iPod Touch (to 
Canadian study 
(adolescents 
recruited from the 
Hospital for Sick 
Children in Toronto, 
ON). 
 
Treatment 
adherence, quality of 
life, self-care 
behaviours, and 
parent-adolescent 
interactions 
regarding T1DM 
were also examined 
(in addition to 
HgbA1c). 
 
Adolescents and 
their parents were 
interviewed 
(separately) during 
the design and 
clinical pilot phases.  
 
Small sample size of 
20 participants. 
 
Length of study 12 
weeks. 
 
No control group. 
 
Tension reported 
between the 
tester/collector and 
analyst/decision maker 
however details not 
available—could this 
have affected study 
results? 
 
Gamification rewards 
(iTunes redemption 
codes) is not 
sustainable long-term 
and may have 
influenced results of 
study. 
No significant changes of HgbA1c 
during duration of the study (9.2% 
pre-intervention (SD 1.03), 8.8% 
post-intervention (SD 0.74); 
p=0.11). 
 
The average daily frequency of 
blood glucose testing increased 
50% (from 2.4 to 3.6 times per day; 
P= 0.006).  
 
Mild improvement between 
adolescent and parent 
communication re. T1DM pre-
intervention/post-intervention. 
 
Survey results from the Diabetes 
Quality of Life (QoL) Instrument 
for Youth identified no change or a 
slighty worse change to QoL 
pre/post intervention. 
 
14/16 participants identified that 
they would continue using the 
application. 
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test if availability of WiFi altered 
the user’s experience).  
 
Gamification incorporated into 
app; rewards earned when the 
adolescent adhered to T1DM 
best-practice guidelines. 
 
Bant app data could be viewed by 
parents’ adolescents online via 
TELUS health space. 
 
Participants were 
varied in their 
insulin 
administration 
method; 9 used an 
insulin pump and 11 
administered via 
injection multiple 
times per day. 
 
Limitations 
identified. 
 
The authors suggest that 
telemedicine in conjunction with 
self-monitoring of blood glucose 
may only be beneficial when there 
is an educational of behavioural 
advice component which may yield 
changes to the individual’s clinical 
management. 
 
mHealth well-received by 
participant’s schools. 
(Carroll et al., 2011) 
 
Title: Using a cell phone-based 
glucose monitoring system for 
adolescent diabetes management. 
 
Quasi-experimental (non-
randomized experimental)/pilot 
study. 
 
Level of evidence: Level III 
 
N= 40  
 
A Glucophone, a cell phone 
glucose monitoring system, was 
developed to send blood glucose 
values to a computer that was 
monitored by an NP. The NP was 
then able to make adjustments to 
Includes both 
adolescent and 
parent perspectives. 
 
Near-balanced ratio 
of male-to-female 
participants (19 
females, 20 males).  
 
The study provided 
compensation ($50 
per survey (3 
surveys in total)) and 
the integrated 
cellphone/glucose 
meter reducing 
socioeconomic 
status as a barrier to 
participation in the 
study. 
Study conducted over 
6 months. 
 
Small sample size- 40 
participants recruited. 
 
Technological 
difficulties were 
significant and may 
have compromised 
results. 
 
No control group. 
Parents and adolescents valued the 
inclusion of an NP. 
 
Average baseline HgbA1c was 8.7; 
60% of adolescents and 46% of 
parents agreed that the HgbA1c had 
decreased during the study however 
the information was self-reported. 
 
The majority of participants 
reported increased independence in 
their diabetic management due to 
the Glucophone. 
 
80% of parents of participants at-
ease with their son/daughter’s 
diabetic management; 66% 
believed their adolescent’s health 
benefited from the intervention. 
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insulin regimens, discuss blood 
glucose values, or make a referral 
with the adolescent and her/his 
parents (as needed) via text 
message (if no response was 
made, the NP initiated a phone 
call). 
 
Feasibility is questioned as the NP 
was working outside of normal 
office hours. 
(Di Bartolo et al., 2017) 
 
Title: Young patients with type 1 
diabetes poorly controlled and 
poorly compliant with self-
monitoring of blood glucose: Can 
technology help? Results of the i-
NewTrend randomized clinical 
trial. 
 
Randomized control trial 
comparing experimental blood 
glucose monitoring with mHealth 
to a traditional SMBG. 
 
Level of evidence: Level II 
 
N= 182 
 
182 participants; 90 
in the Control 
Group, 92 in the 
experimental group. 
 
168 patients 
completed the study. 
 
Randomization 
achieved through 
sealed envelopes. 
 
Thorough statistical 
analysis. 
 
 
Study conducted over 
6 months. 
 
Socioeconomic status 
unidentified; were 
cellular devices 
provided or did 
patients have access to 
a device for the study? 
 
 
HgbA1c changes from the 1st 
month to the 12th month:  
−0.50 ± 0.14% in iBGStar and 
−0.63 ± 0.14% in Control 
(p = 0.64). 
 
Includes quality of life component. 
 
Concludes that telemedicine can 
increase SMBG compliance, 
increased frequency of SMBG 
testing may contribute to HgbA1c, 
few participants in the experimental 
group utilized the full potential of 
the technology available therefore it 
becomes a challenge to identify the 
complete technological benefits, 
and telemedicine may increase 
health care expenditure. 
 
No PCP component. 
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(Dougherty et al., 2014) 
 
Title:  Telemedicine for 
Adolescents with Type 1 
Diabetes 
 
Systematic review yielding 15 
studies. Inclusion criteria 
included: majority age of the 
population between 13 and 18 
years, T1DM, English language, 
telemedicine intervention (studies 
excluded if telemedicine was not 
the sole intervention), and 
evaluation of HgbA1c. 
 
Level of evidence: I 
 
N= N/A 
 
Although the review included 
many modalities of telemedicine 
(videoconferencing, telephone 
calls, etc.), 7/15 studies included 
mHealth; the authors were 
specific as to which article they 
were referring to in the 
results/discussion sections so this 
article is included in this 
integrative review. 
 
 
Relevant grouping in 
the results section—
Automated Systems: 
Mobile Phone 
Communication, 
Interactive Systems: 
Remote Disease 
Monitoring, 
Interactive Systems: 
Phone and Video 
Communication, and 
Smartphone 
Applications. 
 
Worthy amount of 
articles included in 
review (15). 
 
 
Databases limited to 
CINAHL and 
Pubmed. 
 
Methodology does not 
identify if critical 
appraisal was 
conducted by 2 or 
more independent 
reviewers. 
 
No assessment of 
publication bias 
included. 
HgbA1c improved in 10/15 studies; 
statistically significant in 3/10 
studies (1 of those 3 mHealth). 
 
Identifies that telemedicine has 
promise for assisting in the 
management of chronic disease in 
the adolescent population. 
 
Identifies challenges of 
telemedicine: compatibility with 
participant’s personal mobile 
phone, electronic health records 
(EHRs) are not linked directly to 
telemedicine systems (in studies 
analyzed), telemedicine 
interventions that require multiple 
log-ons often have reduced 
compliance amongst participants, 
and studies that did not include 
incentives for participants often had 
lower participants interactions. 
 
Identifies telemedicine can improve 
social support and interaction. 
 
No PCP or healthcare provider 
component included in the 
inclusion criteria, however the 
review identifies that those studies 
that included clinician support and 
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 parental involvement were more 
successful. 
(Frøisland  et al., 2012) 
 
Title: Improving Diabetes Care 
for Young People With Type 1 
Diabetes Through Visual 
Learning on Mobile Phones: 
Mixed Methods Study. 
 
Mixed-methods study measuring 
HgbA1c, the system usability 
scale (SUS) of the mHealth 
applications, and diabetes 
knowledge of the participants. 
 
Level of evidence: Level IV 
 
N= 12 
 
Diamob, a smartphone 
application which utilizes 
smartphone cameras and obtains 
blood glucose data via Bluetooth 
from glucometers, was created to 
monitor dietary intake in 
adolescents with T1DM, their 
pre/post- meal blood glucose 
values, the amount of insulin they  
administered, and physical 
activity information.  
 
Strength in that the 
study is mixed-
methods. 
 
Qualitative data 
analysis conducted 
by two authors 
independently.  
 
Analysis was 
founded on 
phenomenological 
and hermeneutic 
methodology to 
capture the 
participant’s 
experiences. 
 
Dialogue from 
participant 
interviews included 
in the results section. 
 
Statistical analysis 
sufficient. 
Small sample size; 12 
participants (7 girls, 5 
boys), 11 completed 
the study. 
 
No control group. 
 Short intervention 
period of 3 months. 
 
Does not identify if 
interviews were 
conducted individually 
or in groups. 
 
All participants used 
insulin pumps; bias 
results? 
 
Quotes from 
qualitative study 
frequently from same 
participants, were 
participants’ voices 
evenly represented? 
 
Glycemic control improved in 7/11 
participants; mean HgbA1c prior to 
intervention 8.3, post-intervention 
8.1. 
 
HgbA1c improved in 7 participants, 
unchanged in 2 participants, and 
increased in 3 participants. 
 
The mean SUS score was 73, 10 
participants had a mean score of 81; 
2 participants scored 30 (a SUS 
greater than 80 is considered high, 
58 is considered average). 
 
Participants scored similarly 
pre/post study on the diabetic 
knowledge test (mean 22, max. 
possible score 27). 
 
Emphasizes empowerment. 
 
Strong connection identified 
between visuals (photos) and  
ideal diabetic management (as the 
primary visual cortex develops 
earlier than areas of the brain that 
regulate executive function). 
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Furthermore, the Diabetes 
Message System (DMS) was 
created to send SMS messages 
due to strict Norwegian law. 
Reminder messages were sent to 
participants (based on the 
patient’s self-identified 
educational needs) however 
participants could also ask 
questions to a physician. 
 
Participants reported a greater 
understanding of the relationship 
between controlled blood glucose 
levels and insulin; increased social 
acceptance; greater ability to 
manage T1DM independently; and 
improved knowledge, skills, 
attitudes, and awareness of T1DM. 
 
Consensus from adolescents that 
mobile technology was useful in 
managing their diabetes 
 
 PCP interaction: 2 physicians 
responded to messages received via 
the DMS. 
(Mulvaney et al., 2012) 
 
Title: A pilot test of a tailored 
mobile and web-based diabetes 
messaging system for 
adolescents. 
 
Quasi-experimental study. 
 
Level of evidence: Level III 
 
N= 28 
 
A messaging application, 
SuperEgo, was created to assist 
adolescents in managing T1DM. 
Comparison group 
well-matched to 
participants by IT 
specialist not 
involved in the 
research study 
 
Participants had to 
own a mobile phone 
to participate in the 
study. 
 
 
Study conducted over 
3 months. 
 
Small sample size; 28 
participants at 
beginning of study, 23 
completed study. 
 
Average household 
incomes $70,000-
$100,000. 
 
No confirmation that 
messages were read by 
participants during 
study. 
The pilot group maintained their 
HgbA1c values however the control 
group experienced an increase 
(worsening) in their values (p= 
0.006). 
 
Mobile applications are well-
received and can improve 
outcomes. 
 
No PCP involved. 
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Adolescents assisted in creating 
messages for the app (those same 
adolescents were not a part of the 
study). Study participants then 
identified their top 3 barriers; 
75% of the messages sent were 
tailored to their needs. 
Participants were sent approx. 8-
12 messages per week for 3 
months. 
!
